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ABSTRACT 
 
Bacteriophage (phage) Lambda (λ) has played a key historic role in driving our current 
understanding of molecular genetics. The lytic nature of this bacterial virus along with the 
conformation of its wild-type capsid protein (gpD) assembly offer many advantages for the 
virus for a phage display platform. Protein gpD has been used extensively for fusion 
polypeptides that can be expressed from plasmids in Escherichia coli and persevere, or even 
increase, solubility.  
In this study, the exploitation of gpD for the design of a dual expression system for the 
display of enhanced green fluorescent protein (eGFP) was developed and characterized. In 
this system, gpD expression is encoded by mutant  infecting phage particles, λDam, that can 
only produce a wild type length gpD allele within specialized strains of E. coli that can 
suppress the mutation. However, the functionality of gpD alleles, produced by passage of 
λDam through various suppressor strains, varies dramatically in their ability to restore 
functional packaging to the λDam phage, imparting a first dimension of decorative control.   
As a second dimension of decorative control, a D::eGFP translational fusion on a multicopy 
plasmid, encoding gpD::eGFP, complements the Dam mutation in trans and is regulated by 
the temperature-labile  CI[Ts]857 repressor, allowing for the conditional expression of 
D::eGFP by thermoregulation.   
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In combination, the effective exploitation of these two variables has permitted the effective 
development of a fine-tuned λ lytic phage display system. Of the suppressor-imparted alleles, 
gpDQ68S, gpDQ68Y, and gpDwt: the allele with the poorest functionality, gpDQ68S (SupD), 
in combination with submaximal expression of gpD::eGFP conferred the highest 
incorporation of the fusion into the λDam phage capsid in all combinations. Differences in 
size, fluorescence, and absolute protein decoration between phage preparations was achieved 
by varying the temperature of the suppressor host carrying the D::eGFP fusion plasmid. The 
effective preparation with these two variables provides a simple means to manage fusion 
decoration on the surface of phage λ for a variety of fusion partners and applications. 
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Chapter 1: Literature Review of Selected Materials 
 
1 Literature Review of Selected Materials 
This review is adapted from a previously published article in the Journal of Applied 
Microbiology and Biotechnology (Nicastro et al. 2014).  
1.1 Introduction to Phage Display 
Bacteriophage (phage) are bacterial parasites that, like their animal virus counterparts, exist 
in a variety of morphologies and with diverse genetic architectures. Most phage are limited in 
their host range, normally infecting only a single species of bacteria, and often only a subset 
of that species, adsorbing to specific receptors on bacterial cells that define their host range. 
Lytic phage such as T4 and T7 enter immediately into a state of reproduction upon infection, 
lysing the cell. In contrast, temperate phage such as bacteriophage Lambda (λ) “choose” 
between vegetative growth and a quiescent state where the phage genome is stably harbored 
in the host cell in a state called lysogeny. Filamentous phage, such as M13 (Figure 2) and Ff 
do not lyse the cell in any state but rather convert the cell into a phage-producing factory, 
thereby compromising the host’s growth (Gulig et al. 2008).   
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Figure 2: The M13 life-cycle. Phage coat proteins are assembled onto the inner cell 
membrane before ssDNA is packaged into the capsid and the phage are released from the cell 
(Kehoe & Kay 2005). 
 
Bacteriophage display, or phage display (Figure 3), was first developed by George Smith in 
1985 and can be defined as the process by which a heterologous protein or peptide is 
expressed as an exterior fusion through the genetic fusion to a coat protein gene of the 
bacterial virus (phage) particle (Lindqvist 2005). This revolutionary technique, which is one 
of the largest innovations involving phage since their discovery in the early 1900’s (d’Herelle 
& Smith 1926, Duckworth 1976), is based on the genetic fusion, where the outcome of this 
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genotypic manipulation (Kaiser 1966) will produce a phenotypic outcome (Jestin 2008). The 
most well-known phage display methods are based on the usage of phage M13 and the 
related filamentous phage of Escherichia coli. Although filamentous phage are not the focus 
of this review, the principles of their early use govern phage display advancements. The most 
extensively used phage are derived from the E. coli Ff (filamentous) class, where the most 
commonly explored species include M13 (Figure 2), fd and f1. The basic structure of these 
phage consist of a circular single-stranded (ss) DNA genome that is encapsulated by a long 
tube comprised of thousands of copies of a single major coat protein and four additional 
minor capsid proteins at the tips. M13 has been especially useful for phage display as its 
genome is bound only by the major coat protein (as opposed to filling a phage head 
structure).  Therefore, there is not a strict limit on the size of packaged DNA permitting for 
more opportunities for manipulation.  Smith (1985) was the first to successfully demonstrate 
a phage capsid fusion by inserting an external gene into the phage genome of fd. This 
construct demonstrated the efficient display of EcoRI endonuclease gene product on the fd 
minor coat protein pIII (Smith 1985, Smith & Huggins 1982). Based on this initial work, 
lytic phage, including phage T4 and T7, and temperate phage λ would eventually be 
successfully exploited as fusion vectors as well (Garufi et al. 2005, Kalniņa et al. 2008). 
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Figure 3: Schematic for phage display. Foreign peptides can generally be displayed on 
more than one peptide and in varying amounts. The amount of peptides that a phage can 
tolerate will generally depend on the size of the fusion, where smaller peptides can be 
tolerated in higher amounts. Fusions may also occur concurrently on minor and major coat 
proteins, as well as simultaneously on both the N-and C-terminals of the same coat protein. 
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1.2 Lytic vs. Filamentous Phage Display 
The use of filamentous phage in display technology possesses major limitations that can be 
overcome with lytic phage display systems. First, a tolerated fusion must have the ability to 
translocate across the plasma membrane and as such, many hydrophilic cytoplasmic proteins 
cannot be extruded as fusion proteins in filamentous phage, where phage assembly occurs 
onto the inner cell membrane (Figure 2).  Second, filamentous phage are severely constrained 
by the size of fusions possible (Garufi et al. 2005, Mikawa et al. 1996, Sternberg & Hoess 
1995). Third, filamentous phage are dependent on the viability of the host and thus, cannot 
effectively display peptides/proteins that are toxic to the cell (Garufi et al. 2005). Due to the 
lytic nature of double-stranded (ds) DNA bacteriophage, the fusion of toxic proteins is no 
longer a concern in temperate or lytic phage as the phage protein development is repressed in 
the phage lysogenic state (temperate phage only) and occurs just prior to cell lysis (Garufi et 
al. 2005). 
A few lytic phage candidates have been identified for phage display such as λ, T4 and T7. 
The C-terminal of T4 minor capsid proteins Hoc and Soc tolerate fusions for lytic phage 
display (Efimov et al. 1995, Ren et al. 1996). Phage T7 has been employed as a display 
platform for various GFP-based cytoplasmic proteins that showed poor expression 
(fluorescence) with more traditional filamentous display vectors (Dai et al. 2008). Santini et 
al. (1998) developed the first chimeric phage system in which C-terminal fusions were made 
to the λ major capsid protein gene product D or gpD. Recombinant phage were decorated 
with both wild-type gpD and proteins from a hepatitis C virus (HCV) cDNA expression 
library. These recombinant phage were compared to two other libraries (N-terminal fusions 
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to the pIII and pVIII capsid proteins of M13) using the cDNA expression library. In order to 
avoid overpopulating the λ phage with gpD fusions, and improve the phage stability, they 
expressed a second D allele possessing an amber mutation within the gene for gpD. This 
addition to the phage display process allowed for the formation of chimeric phage (Santini et 
al. 1998).  Comparing the filamentous phage proteins, pVIII’s display was more efficient 
than pIII, and when pVIII was compared to gpD display and selection of protein fragments of 
limited size, the two libraries showed comparable efficiencies. However, when larger protein 
fragments were tested, gpD outperformed pVIII. This result was attributed to the absence of 
the requirement of  to secrete the fusion protein. So unlike filamentous pIII/VIII, larger 
recombinant proteins can fold properly without interfering with phage assembly while 
displaying higher densities (Santini et al. 1998). 
Gupta et al. (2003) later designed a λ phage display library that expressed fusions on the C-
terminal of gpD. This library was compared to one created by fusing to an M13 phage (N-
terminal fusions made utilizing major coat protein PVIII and minor coat protein PIII) where 
there was no degradation of displayed products. This  display system provided a 100-fold 
higher display for all fragments compared to filamentous phage. The  system generally 
displayed proteins of different sizes, where the number of fusions/phage particle was 2-3 
orders of magnitude greater than that for M13. When the high-density display was applied to 
epitope mapping, the  system consistently outperformed M13 with a higher ELISA 
reactivity shown. 
 7   
 
1.3 Bacteriophage  Phage Display 
Bacteriophage λ is one of the most well-studied model temperate bacteriophage to date. 
Much of what we know about viral and bacterial genetics is owed to previous work in λ 
phage genetics and regulation.  When fully formed, bacteriophage  has a linear dsDNA 
genome harboured within an icosahedral capsid, and a flexible, non-contractile tail (Ling et 
al. 2011, Roberts & Devoret 1983). A great deal of work has been done investigating the 
genetic switch between lytic and lysogenic states (Ptashne 2004) and the phage’s assembly 
(Roberts & Devoret 1983).   
The icosahedral-shaped bacteriophage λ capsid is approximately 60 nm in diameter with a 
shell thickness of about 4 nm and accommodates the λ genome of 48.5 kb (Hohn & Katsura 
1977, Witkiewiczl & Schweiger 1982). Phage λ assembles its head in two steps: prohead 
assembly followed by DNA packaging. Casjens and Hendrix (1974) identified and described 
that gene product E (gpE) and gene product D (gpD), comprise the λ icosahedral capsid 
(Georgopoulos et al. 1983). The λ prohead shell is composed mainly of gpE in approximately 
415 copies. DNA packaging requires a conformational change to the prohead via the addition 
gpD to the prohead, which increases the head volume and stability (Georgopoulos et al. 
1983, Yang et al. 2000). Gene product D is present in 405-420 trimer-clustered molecules 
(Figure 4) and although it is not required for prophage head assembly, it is essential for the 
packaging of a full-length genome (Beghetto & Gargano 2011). In contrast, gpD deficient 
viruses can package up to 82% of the wild-type genome (Dokland,T., Murialdo 1993) but 
need to be stabilized by  magnesium ions, and are extremely sensitive to the divalent cation 
chelator, EDTA (Sternberg et al. 1979, Yang et al. 2000).  It has also been suggested that 
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gpD acts by physically blocking the DNA from leaking through the shell (Dokland,T., 
Murialdo 1993). Like eukaryotic chromosomal proteins, the gpD proteins are able to cross-
react immunologically with eukaryotic histones, which may pertain to gpD’s function in the 
stabilization and compaction of phage DNA (Wendt & Feiss 2004).  
 
 
 
 
 
 
 
Figure 4:  One face of bacteriophage. The illustration depicts one of the 20 faces of the 
bacteriophage  capsid head. Protein gpD (the decoration protein labeled “D”) is 
incorporated in homotrimers at 405-420 molecules per capsid, and protein gpE (the other 
major capsid protein labeled “E”) is incorporated, at same number, into homohexamers. 
 
1.3.1 Protein gpD as the Lambda Fusion Protein: 
Initial  λ phage display fusions were fused onto gpV, the major tail protein, present in 192 
copies (Dunn 1995) per phage particle. Maruyama et al. (1994) successfully displayed fusion 
proteins β-galactosidase and BPA to the C-terminal domain of gpV.  They did however, 
discuss limitations to gpV fusions such as the very low fusion expression of less than one 
fusion/phage particle (Maruyama et al. 1994, Mikawa et al. 1996). It has been suggested that 
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the fusion proteins may interfere with the tail assembly, imparting the low yield (Maruyama 
et al. 1994).  They also demonstrated conditional fusions through the use of an amber stop 
codon between the gpV protein at the C-terminal and the gene encoding the fusion enabled 
functional tail formation (Maruyama et al. 1994), where the display of shorter peptides has 
since been reported to be well tolerated in all 192 copies (Dunn 1995, Katsura 1983, Zanghi 
et al. 2007). Phage display fusions on gpD confer a high decoration capacity per phage 
particle (up to 420) in comparison to the gpV tail protein (~1) (Maruyama et al. 1994, 
Mikawa et al. 1996) and are conditionally required for phage head assembly compared to 
gpE, which is absolutely required (Mikawa et al. 1996, Sternberg & Hoess 1995).   
Cryo-electron microscopy and image processing of gpD have shown that the major capsid 
protein assembles in homotrimers that are incorporated as prominent protrusions on the 
surface of the phage capsid, making them more accessible for binding to external target 
molecules (Figure 5) (Dokland, Murialdo 1993; Sternberg & Hoess 1995). The use of gpD to 
express peptides on the λ capsid is ideal since both the N- and C-termini protrude outward, 
exposing them to tolerate the  addition of fused peptides (Mikawa et al. 1996, Witkiewiczl & 
Schweiger 1982) 
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Figure 5: Protein gpD trimers bound to the icosahedral surface of phage λ. The overall 
network of interactions shows the pattern of gpD. The protein is incorporated at 
approximately 405-420 copies on the phage λ head and can be seen as strongly protruding 
thimble-shaped trivalent spikes (Lander et al. 2008). 
 
1.3.2 Amino vs. Carboxy Fusions to gpD 
As previously mentioned, the λ gpD protein is tolerant of various protein and peptide fusions 
to the N- and C-termini (Figure 6) of the major capsid component, providing great flexibility 
to this lytic phage display system. Pavoni et al. (2004) constructed a tumor cDNA display 
library employing the N-terminal for fusions to gpD in order to prevent the selection of out-
of-frame fusions. As such, the recombinant phage can be decorated solely with gpD fusions 
(Minenkova et al. 2003, Pavoni et al. 2004). Both the use of an N-terminal fusion and 
engineered phage allow for simpler assembly of chimeric phage, but the use of enhanced 
green fluorescent protein (eGFP) as an N-terminal fusion partner does not allow for proper 
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folding of eGFP, compromising its fluorescence in the fusion (Pavoni et al. 2004). Zucconi et 
al. (2001) determined that the number of tolerable fusion proteins displayed on the capsid 
surface is dependent on the length of the display protein. Furthermore, the group also 
reported that high incorporation rates is achieved by fusion to either the N- or the C- 
terminus. These groups provided important initial insight into the ability of gpD fusions to 
retain function and thus, for phage to assemble properly and form viable phage particles 
(Minenkova et al. 2003, Zucconi et al. 2001).  
Yang et al. (2000) used cryo-electron microscopy to show that the N-terminus of gpD is 
conditionally disordered when unbound and may interact with gpE. Any fusions to it requires 
the interaction of the N-terminal fusion linker with gpE to display the fusions on the outside 
of the fusion proteins. This claim is supported by a study by Lander et al. (2008) where a 
cryo-electron microscopy reconstruction of the  capsid head was developed and showed that 
the first 14 residues in gpD N-terminus interact with a strand of an E-loop in gpE and 
together form a stable β-sheet. This combination allows for the stabilization of the phage 
head.   
Vaccaro et al. (2006) fused a functional scFv antibody to the N- and C-termini of gpD and 
found that the N-terminal fusions showed a relatively low recombinant protein loading in 
comparison to the C-terminal fusions (50% compared to 88%). The C-terminal fusions also 
presented unusually small plaques, which suggested that the large scFv protein was 
compromising phage assembly. They also performed phage stability assays via 
immunoscreening, and observed that while N-terminal phage produced expected results, one 
to five percent of plaques generated by C-terminal fusions were larger in size and negative 
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for the assay. These plaques were later found to be mutants possessing point mutations 
caused either by frame-shift or premature stop signal point mutations within the scFv gene, 
suggesting a powerful selection against the inefficient display of the antibody as a C-terminal 
fusion and the inhibitory effect on the assembly of viable phage (Vaccaro et al. 2006).  
 
Figure 6: Isolated density pertaining to gpD. The gpD protein is depicted from the top, 
side and bottom, respectively (left to right) from a crystallized fit into a reconstructed EM 
structure density.  The N-termini of the gpD homotrimer can be seen extending away from 
the main body. The N-terminus requires the mature capsid substrate for stabilization (Lander 
et al. 2008). 
 
 
 13   
 
1.4 Genetic Control Systems 
1.4.1 Amber suppression: 
Amber suppression is a form of conditional suppression of nonsense codon mutations. 
Theoretically, a second host site (suppressor) mutation permits a read through of the amber 
stop codon and insertion of an amino acid (a.a.) in lieu of premature termination. The largest 
class of nonsense suppression is mediated through tRNA genes where a mutant allele coding 
for a tRNA of the E. coli host (Figure 7) has a modified complementary anticodon for the 
stop codon which inserts an a.a. in place of the stop codon. This functions to  suppress (or 
prevent) termination (Taira et al. 2006). Amber suppression is specific to the amber (UAG) 
stop codon (Benzer & Champe 2013, Inokuchi et al. 1979). Other classes of nonsense 
suppressors include ochre and opal suppressors that recognize UAA and UGA stop codons, 
respectively, in accordance with Weigle Rules, where both G=U and A=U base pairing can 
occur (Eggertsson & Söll 1988). Suppressor tRNA is in competition with translation 
termination factors; therefore the suppression efficiency will be leaky and typically less than 
100% (Normanly et al. 1986). 
 Two translational outcomes occur in suppressor strains: i) non-functional protein 
truncations; and ii) full-length species conferring partial to complete function. Restoration of 
the wild-type pristine protein sequence, or a protein sequence that is identical to the original, 
is preferable to most closely mimic the properties of the original protein (Normanly et al. 
1986).  
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Figure 7: Amber suppression of the  Dam15 allele. Amber suppressor strains of E. coli 
possess a mutation that alters tRNA activity, which pairs a charged mutant tRNA with the 
amber mutation (UAG) and inserts an a.a. in the place of the stop codon. This results in the 
full translation of a wild-type length allele of gpD.  
 
 
 15   
 
1.4.2 Temperature-conditional λ CI[Ts]857 Repression 
Lieb (1966) first characterized the λ CI[Ts]857 temperature-labile repressor and discovered 
that it was the dissociation of this repressor complex that allowed downstream transcription 
to proceed from the λ rightward (PR) and leftward (PL) strong promoters (Lieb 1966, 
Szybalski et al. 1969). It is the controllable nature of this repressor associated with 
expression from a strong promoter that made temperature-sensitive cI[Ts] alleles attractive 
for use in cloning vectors to regulate expression of the gene of interest. In these cases, a 
single copy of the cI[Ts] gene produces enough repressor to effectively inhibit the PL or PR 
promoters on single or multicopy replicons (Bernard et al. 1979, Lukacik et al. 2012, Remaut 
et al. 1981). Under this repressor-regulated promoter’s control, a downstream gene is 
expressed at increasing levels as temperature increases due to the temperature lability of the 
CI857 allele. Thermal sensitivity may not be as tightly regulated as chemical induction 
approaches, but is less likely to be genotoxic, and provides controllable expression attributes 
that are very favourable. The most common CI857 allele is also “Ind-” that renders the 
repressor resistant to RecA-catalyzed autocleavage, and thus insensitive to other mutagenic 
inducers such as UV lending further control over expression (Mott et al. 1985, Ren et al. 
1996). The CI857 allele denatures completely at 40-42C, conferring maximal expression of 
the gene of interest (Hayes & Hayes 1986). Conversely, temperatures as low as 29C may be 
required to fully repress transcription from PL via the CI857 allele, and highest protein yields 
can be obtained following induction at 36C. The temperature efficiency depends on the 
protein being expressed and the host cell; the expression of many heterologous proteins 
innately affect bacterial cell growth and survival (Guzmán et al. 1994, Jechlinger et al. 1999, 
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Lowman & Bina 1990, Villaverde et al. 1993). Strategies to avoid protein expression toxicity 
include: i) suppression of basal expression from leaky inducible promoters; ii) suppression of 
read-through transcription from cryptic promoters; iii) tight control of plasmid copy 
numbers; iv) protein production as inactive (but reversible) forms; and v) the creation of 
special expression vectors and modified E. coli strains (Saïda et al. 2006). The CI857 
repressor activity is not limited to E. coli; it has also been effective in gram-positive strains 
such as Bacillus subtilis, where downstream expression efficiencies were found to be similar 
to those reported in E. coli with only minor codon bias modifications required (Breitling et 
al. 1990).   
1.5 Controllable Phage Display Systems 
Since the development of significant applications derived from the original work on lytic 
display, control of fusion copy number has been generally underdeveloped. The number of 
tolerable fusions per phage particle is thought to depend on the size of the fused fragment.  
Smaller fusion fragments are expected to be tolerated in greater numbers in comparison to 
their larger counterparts (Gupta et al. 2003). When comparing strategies for the development 
of a vaccine versus a vector for gene delivery or fusion of a peptide versus a large multimeric 
protein, many different approaches must be applied due to the differentiation in fusion 
number. In addition, various factors must be taken into consideration for various downstream 
applications, including but not limited to: i) the occurrence of over-stimulating a signal due 
to high affinity or high avidity interactions; ii) the possibility of cross-reactivity and steric 
hindrance impeding protein function; and iii) ligand access. The control over fusion 
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decoration is of paramount importance particularly toward the development of phage 
therapeutics (Figure 8).  
Mikawa et al. (1996) were first to employ amber suppression to regulate gpD. Although the 
approach was qualitative and based on relative display, more modern approaches were used 
to generate gpD fusions in vivo. These systems were able to generate libraries and purify 
functional fusions, increase the size and density of capsid fusions, and recently tackle the 
issue of copy control (Lankes et al. 2007, Mikawa et al. 1996, Nicastro et al. 2013, 
Sokolenko et al. 2012). Two unique vector features used in these initial constructs included a 
peptide linker and the conditional fusions via amber suppression strategies that permitted the 
fusion of multimeric proteins. There was only a slight difference in expression when 
suppression was used as a crude control mechanism for capsid fusion expression by 
employing various allogeneic E. coli suppressor strains SupE, SupF, SupD, Sup—, coding for 
glutamine, tyrosine, serine or no residue (stop) at the site of the amber stop signal, 
respectively (Maruyama et al. 1994, Mikawa et al. 1996).  
 
 
 
 
 
 18   
 
 
 
 
 
 
 
 
 
Figure 8: Schematic of controlled phage display on the phage λ capsid. Decoration of the 
λ capsid under controlled circumstances will result in a display platform, whereby both the 
fused protein and the wild-type protein are incorporated into the capsid head. The schematic 
shown here represents a 50% decoration rate. i.e. 50% of the gpD positions are filled with 
gpD:X fusions labeled “D:X” and 50% are filled with wild-type gpD labeled “D”. 
 
 
1.6 Phage Display Applications 
The small-size and the enormous diversity of variants that can be fused to the bacteriophage 
capsid make phage ideal candidates for numerous applications across many industries. Some 
primary applications include targeted therapy and detection, and conjugation with 
macromolecules in medicine, plant science and nanoparticles in materials science (Petty et al. 
2007, Willats 2002). Initially, phage display was developed to display random and natural 
peptide libraries (Dulbecco 1982). Random peptide libraries consist of synthetic random 
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degenerated oligonucleotide inserts that are used to identify linear antigenic epitopes and 
offer a universal application base. In contrast, natural peptide libraries that are composed of 
randomly fragmented DNA from the genomes of selected organisms may be used to identify 
vaccine components and bacterial adhesins, although most of these clones are nonfunctional 
(Mullen et al. 2006).  Since initial lytic phage display design studies, a great deal of attention 
has been focused on progressing towards the development of novel therapeutic or industrial 
applications for the system; recent studies combine the genomic flexibility of phage with 
phage display to generate genomically modified phage for targeted gene delivery. The list of 
applications is far too large for a comprehensive review so the following topics have been 
selected, based on significance and extensiveness in the field.    
1.6.1 Phage Vaccines  
As vaccine delivery vehicles, bacteriophage vectors offer a strong alternative to the more 
classical viral and non-viral systems since they possess inherent attributes that permit them to 
overcome the challenges that generally limit the utility of traditional approaches. The 
dimensions of phage λ are very similar to many mammalian viruses and may even share 
some of the same ancestry (Zanghi et al. 2007).  They are also endowed with many of the 
intrinsic mechanisms of mammalian viruses,  such as cell entry and endosomal escape, and 
while perhaps not as efficient as their eukaryotic viral counterparts, these attributes provide 
an advantage over non-viral vectors (Min et al. 2010). As phage exclusively infect bacteria 
and are ubiquitous inhabitants of our natural habitat, it is not surprising that they have also 
been proven to be completely safe in mammalian systems and are free of many of the serious 
side-effects attributed to mammalian viral vectors (Min et al. 2010, Seow & Wood 2009). 
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Phage vaccine delivery follows many of the same steps required in the delivery of other non-
viral vectors. Research is currently focusing on optimizing the binding and internalization of 
phage by antigen presenting cells (APCs). However, the mechanism by which phage deliver 
their DNA cargo to the nucleus once the particle has been internalized is not well understood. 
It appears that the internalization of targeted phage particles is quite efficient, whereas 
endosomal escape and nuclear uptake is not (Larocca & Baird 2001). Despite this limitation, 
phage-based vaccine delivery has been successfully implemented employing two different 
strategies: i) direct vaccination via the manipulation of the phage to display the protective 
antigen on the surface coat proteins; or ii) using the phage particle as a delivery system for a 
DNA vaccine expression cassette containing the sequences required for vaccine antigen 
synthesis packaged into the phage genome (Clark & March 2006, Seow & Wood 2009).  
(See Figure 9 for a diagram on the examples of phage-based vaccines).  
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Figure 9: Phage vaccine delivery techniques. There are many ways that phage can be used 
as vaccine delivery vehicles. It is important to note that the hybrid phage depicted above has 
been shown to display the protective antigen on the capsid surface; the hybrid phage can 
display other peptides as well, including targeting peptides designed to increase uptake of the 
particles. Many phage display techniques can also display multiple peptides on the surface. 
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The use of phage for targeted DNA delivery offers the inherent advantage of the phage 
capsid, which can act to protect the DNA within from degradation once it has been injected, 
thereby acting as a DNA vaccine (Haq et al. 2012).  It has also recently been shown that 
vaccination strategies involving phage carrying DNA are more efficient than naked DNA 
vaccine strategies (Clark & March 2004, Clark et al. 2011, Haq et al. 2012, March et al. 
2004). A potential third strategy combines the above two methods to develop a “hybrid” 
phage. These phage are specifically engineered to display both the antigen of interest as well 
as the gene of interest in the genome of the phage for a combined effort. The displayed 
peptide may also be used as a targeting ligand for the delivery of the phage to specific 
immune cells and enhance the delivery efficiency (Min et al. 2010; Clark & March 2006; 
Lankes et al., 2007).  
Phage are considered to be natural immunostimulators, where the carrying particle can serve 
as a natural adjuvant (Clark et al. 2011). This adjuvant effect of phage has been hypothesized 
to be related to the presence of i) CpG motifs on the foreign phage DNA; and ii) the virus-
like repeating structure of the phage coat. It has been demonstrated that the CpG motifs on 
the phage DNA are likely responsible for the stimulation of the Th1 immune response in mice 
when delivered with recombinant Hepatitis B antigen (Malanchère-Brès et al. 2001) and the 
stimulation of B-cell responses (Clark et al. 2011, Li et al. 2012). Clark et al. (2011) 
demonstrated that phage have an increased antibody response measured after vaccination in 
comparison to the standard recombinant protein vaccine Engerix for the treatment of 
Hepatitis B in rabbits. Ling et al. (2011) also demonstrated that mice vaccinated with a phage 
vaccine expressing a DNA expression cassette for the treatment of Chlamydiphilia abortus 
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had higher levels of immune cell and cytokine responses in comparison to those treated with 
a naked DNA vaccine, although the immune response levels were not as high as those from 
the attenuated commercial vaccine (Ling et al. 2011).  The natural immunostimulatory effect 
of phage speaks to the potential for phage based vaccines since the phage already possess the 
natural ability to stimulate an appropriate immune response. 
Bastien et al. (1997) employed phage fd to display a chimeric protein with a proven 
protective epitope, G glycoprotein, against human respiratory syncytial virus (RSV), to 
explore the use of filamentous phage in the development of vaccines. This study showed that 
mice acquired complete resistance to a viral challenge by the absence of the virus in their 
lungs and high levels of RSV-specific antibodies. In addition, the level of antibody was only 
slightly lower than immunized mice with whole RSV virus. This was also the first study that 
showed recombinant phage can be selected directly from random peptide libraries and then 
used directly for protection assays (Bastien et al. 1997).   
March et al. (2004) first employed λ as an encapsulated DNA vaccine where they immunized 
mice with λ particles encoding either eGFP or hepatitis B surface antigen (HBsAG). The 
expression system protected the DNA cargo until it was safely within the cell, but these 
particular constructs did not display the protein on the phage surface (Jepson & March 2004). 
Both of these modified DNA vaccine constructs were able to elicit an immune response in 
mice, but results were inconsistent. The group suggested that the display of antigens on the 
surface of the phage, rather than solely a DNA format, may grant a more specific and 
effective vaccine approach.  
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This peptide display approach was realized when Zanghi et al. (2005) developed a mosaic 
expression approach to circumvent the issue of recalcitrance by decorating λ with wild-type 
and recombinant proteins in tandem. This system utilized two separate plasmid constructs 
that contained different origins of replication and selectable markers that were co-
transformed into a gpD-deficient λ lysogen (Zanghi et al. 2005).  When only the recombinant 
plasmid was expressed, no viable progeny were recovered, indicating that the fusion must 
either interfere with assembly or prevent formation of stable phage particles. Like wild-type 
phage, the slight reduction in mosaic phage titers could be attributed to plasmid attributes—
mainly copy number and protein expression. With the presence of two plasmids that have 
theoretically consistent expression and fusion capacities, the level of control is still quite 
limited. 
Thomas et al. (2012) recently developed a λ vaccine using a combination of cis (via 
recombination) and trans (plasmid-mediated) peptide phage display to elucidate how peptide 
immunization might be superior to genetic immunization. They found that phage-based 
peptide expression vectors elicited a greater immune response at a physiological pH in higher 
primates and humans in the absence of an adjuvant than genetic vaccine (Thomas et al. 
2012). They also developed a divalent subunit vaccine that was a hybrid of a DNA and a 
peptide vaccine with two separate fusions to gpD—one with GFP and the other with the TAT 
protein from HIV-1 that proved to be superior to the peptide vaccine. The TAT protein was 
specifically chosen for its ability to efficiently deliver to mammalian cells (Eguchi et al. 
2001). Both fusions were constructed to the C-terminal of gpD and a short linker was placed 
between the two protein domains, which were displayed on the phage surface in tandem. The 
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same phage that lacked display for either of these two proteins was used as the DNA vector 
for comparison. Similar to the system here, the plasmid expressing the fusion was inducible 
by IPTG and the recombineered genome was passaged through a SupF (Tyrosine) host. In 
each case, the primary immune response was humoral and λ served as an endogenous 
adjuvant where the phage that displayed the two peptides outperformed the non-displaying 
DNA vaccine (Thomas et al. 2012). The preparation process improved as the temperature-
inducible promoter used in the system for this research study only required a change in 
temperature as opposed to chemical inducers.  
Hayes et al. (2010) developed a λ-based vaccine where the construct had multiple fusions to 
the C-terminal of gpD—one in which four immunodominant regions of the porcine 
circovirus capsid were fused, a second with GFP, and the third with a SPA tag protein. 
Interestingly, the GFP and the circovirus capsid fusions could be expressed constitutively 
without compromising the viability of the host, while the SPA expression reduced phage 
viability by more than 50-fold, likely due to recalcitrance. Recalcitrant fusions prevent 
protein oligomerization and the formation of homotrimers during phage assembly and 
therefore display fewer D-fusion proteins which compromise phage stability. The circovirus 
capsid fusions were also able to elicit both cellular and humoral responses in pigs (Gamage et 
al. 2009, Hayes et al. 2010).  
A more recent commercial example of phage display employed λ phage scaffold decorated 
with HIV-1 envelope protein (Env) via in vitro complementation, where the immune 
response elicited was compared to that of soluble gp140. This strategy was employed 
because in their native state, envelope spike proteins are sparsely present on the HIV-1 virion 
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and the ability to increase their density on the phage capsid could in theory generate an 
improved immune response. Phage were decorated with a mixture (different molar ratios) of 
gpD:gp140 and wild-type gpD protein. Like Zanghi et al. (2005), Hayes et al. (2010), and 
Mattiacio et al. (2011) discovered that phage were recalcitrant and unstable when decorated 
completely with a 20-fold molar excess of fusion protein. They also determined that some 
fusion proteins could stabilize phage particles even when they only occupy a fraction of the 
gpD binding sites and that the number of fusions incorporated into the capsid was only 30 
copies of Env trimers per particle (Zanghi et al. 2005; Hayes et al. 2010; Mattiacio et al. 
2011; Nicastro et al. 2013). As a result, the investigators did not observe an increased 
immune response to the decorated phage compared to the conventional protein (Mattiacio et 
al. 2011). Each of these groups also executed codon optimization in developing their 
constructs, which allowed for more efficient protein expression and less homology of fusions 
to native  sequences, thus decreasing the potential for homologous recombination between 
alleles (Zanghi et al. 2005).  
Although phage vectors offer promising advantages, they are not without their limitations. 
Phage are rapidly removed by the reticuloendothelial system, contain potent antigens (Seow 
& Wood 2009), and generally offer a lower efficiency of gene delivery relative to their viral 
counterparts (Larocca & Baird 2001). While these limitations will require further attention, 
the advantages imparted by phage as single administration gene and vaccine are many and 
suggest powerful potential for their use in future vaccine development (Seow and Wood 
2009). 
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1.6.2 Phage as Gene Transfer Vehicles  
Bacteriophage offer strong potential as gene transfer vehicles, particularly due to the fact that 
their coat proteins can protect DNA cargo against degradation during delivery (Clark & 
March 2006, Dunn 1996). Additionally, the tolerance of capsid fusions makes it possible for 
display phage to target specific cells of choice (Clark & March 2006), a cornerstone of 
successful gene therapeutic design. Fibroblast growth factors have been used as targeting 
sequences for the delivery of phage to cells that have the appropriate receptors (Hart et al. 
1994, Sperinde et al. 2001). These sequences have been shown to  enhance the uptake and 
endosomal release of phage via proteins such as penton base of adenovirus which mediates 
entry, attachment and endosomal release (Haq et al. 2012, Piersanti et al. 2004). The 
transduction domain of HIV (Human Immunodeficiency virus) or the TAT protein, and the 
Simian Virus 40 (SV40) T-antigen nuclear localization signal have also been exploited to 
enhance cellular uptake and nuclear localization of lambda phage, respectively (Nakanishi et 
al. 2003). 
The first reported use of filamentous phage for gene transfer and delivery was reported by 
Hart et al. (1994). In this study, phage fd was employed to display a cyclic-binding peptide to 
the major coat protein pVIII. This N-terminal fusion, occurring at approximately 300 
copies/phage particle, was bound to cells and was efficiently internalized. The same peptide 
sequence was then fused to the major tail protein (gpV) of λ. These modified phage proved to 
be a more suitable candidate by transfecting mammalian cells at a remarkable frequency in 
comparison to the controls (Dunn 1996, Hart et al. 1994).  
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 Lankes et al. (2007) expanded the application of λ as a gene delivery vector by executing 
phage-mediated gene transfer in vivo.  The group constructed recombinant λ particles 
encoding firefly luciferase (luc) in order to visualize gene delivery in real-time via the use of 
bioluminescence imaging (Lankes et al. 2007). They fused a v3 (CD51/CD61) receptor 
integrin-binding peptide to gpD to increase its uptake by receptor-mediated pinocytosis. This 
integrin was chosen because it is known to play a role in the binding/internalization in a 
number of mammalian viruses and it had been used to enhance the targeting of modified viral 
vectors to dendritic cells.  The study showed preferential internalization of fused phage over 
their non-fused counterparts, where internalization decreased in a dose-dependent fashion.  
Vaccaro et al. (2006) noted a similar pattern of internalization following the addition of 
competitor proteins, indicative of a receptor-mediated process. The recombinant phage 
outperformed the control cells both in vitro and in vivo. In addition, they noted a 100-fold 
increase in phage internalization into integrin-positive versus control cells, but only a 3-fold 
increase in phage-mediated gene expression. This indicated that the level of internalization is 
not necessarily comparable to the successful delivery of genetic material (Vaccaro et al. 
2006). Overall, this study provided a proof-of-concept for the use of recombinant phage to 
increase the gene transfer in vivo and a compelling argument for the use of phage in 
transgene delivery (Lankes et al. 2007, Vaccaro et al. 2006).  
Zanghi et al. (2007) explored construct design, where they attempted to improve phage- 
mediated mammalian gene delivery of a luciferase gene through the simultaneous fusion of 
proteins to both the head and tail of phage λ. Multiple intracellular barriers such as cell 
attachment, cytoplasmic entry, endosomal escape, uncoating and nuclear import, must be 
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overcome for successful gene transfer (Seow & Wood 2009).  Multiple peptides could 
theoretically be displayed in tandem, where each peptide could function to circumvent a 
separate barrier. In addition, the system could potentially target intracellular pathogens to 
overcome intracellular barriers, where a lower density display would presumably be 
employed for ligand interaction and receptor-mediated endocytosis, while a higher density 
display could be used to target a pathogen. The group reported an average number of fusions 
per phage particle to be ~400 copies/phage particle for gpD and ~100 copies/ phage particle 
for gpV (Zanghi et al. 2007).  The group also supplemented the efficiency of phage-mediated 
gene transfer in a murine macrophage cell line with the surface display of an ubiquitinylation 
motif and the system was further improved by the simultaneous tail fusion of a CD40-
binding motif (Zanghi et al. 2007). 
Sapinoro et al. (2008) explored pre-immunization as an approach to increase the uptake of 
recombinant phage, termed antibody-dependent enhancement (ADE). In concept ADE relates 
to the observation that opsonization, or binding of antibodies to an antigen, permits the more 
efficient infection of susceptible host cells such as monocytes and macrophage that possess 
receptors for the antibody isotype. The objective of the group was to develop an in vitro 
model for this phenomenon in mammalian cells by bacteriophage λ vectors and determine 
their mechanisms. Since it is known that this effect can be mediated through cellular 
receptors specific for the Fc portion of IgG, the group used a cell line expressing human Fc 
gamma receptor (FcR) and found that ADE of phage-mediated gene transfer required the 
receptor on the surface of target cells (Sapinoro et al. 2008). In addition, prior immunization 
with wild-type phage resulted in more efficient phage-mediated gene expression in live mice 
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and this increased transduction was undertaken through a receptor-mediated endocytic 
mechanism rather than through phagocytosis (Sapinoro et al. 2008).  Overall, this research 
study showed that the system was advantageous toward the development of downstream 
vaccines and targeted gene therapy approaches. 
Although numerous methods have been developed for gene delivery, an efficient platform for 
protein delivery and more specifically protein delivery in tandem with gene delivery does not 
currently exist. Recently, Tao et al. (2013) developed a T4 DNA packaging machine using 
T4-based “progene” nanoparticles that were targeted to antigen-presenting cells and were 
expressed both in vitro and in vivo. The group fused DNA molecules on the capsid head 
proteins Soc and Hoc that would later be displayed on the phage heads. Foreign cell 
penetration peptides (CPPs) and proteins (β-galactosidase, dendritic cell specific receptor 205 
monoclonal antibody, and CD40 ligand) were chosen for display onto Hoc. The encapsidated 
DNA included GFP and luc (luciferase) genes to enable quantifiable expression within 
mammalian cells. Overall, the group showed evidence for efficient in vitro and in vivo 
progene delivery and expression of self-replicating genes into mammalian cells.  Although 
the results were promising, there is room for further investigation particularly with respect to 
the in vivo studies where, unexpectedly, the strongest luciferase signal came from mice 
infected with the nanoparticles that did not display a targeting ligand. The authors have 
attributed this finding to migration of the targeted cells to other parts of the body; an 
inference that will require further investigation (Tao et al. 2013).  
When undertaking a vaccination approach, high-density display may be preferred as 
functions of the fused protein may not be critical. In contrast, an application such as targeted 
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gene therapy relies upon ligand interaction and proper folding/function of the fusion to 
improve cell specificity or enhanced endocytosis. The ability to control the number of fusions 
provides power and flexibility to cater mosaic phage to different scenarios and needs.  
Moreover, the ability to control the number of fusions and gpD molecules could reduce the 
chance of recalcitrance and improve viability. Finally, this system can be expanded to 
generate multiple fusions and polyvalent therapeutics.  
1.6.3 Phage as Bacterial Sensors 
There is a strong and growing demand for new technologies that can detect pathogens in 
food, water, and environmental and patient samples, provided that they can address a real 
need: i) pathogen detection in food, water or air to identify pathogens or agents of 
bioterrorism before they can cause harm; ii) diagnose disease early so appropriate therapy 
can be administered; or iii) identify disease-causing organism(s) to permit preventative 
measures and detect ongoing outbreaks (Gulig et al. 2008). Classical methods of bacterial 
detection employed biochemical tests that can be time consuming and require microbes to 
grow on differential media. More recently, significant efforts have been applied to nucleic 
acid detection (i.e. real-time PCR) and the use of enzyme-linked immunosorbant assay 
(ELISA), antibody arrays, fiber optics and surface plasmon resonance to detect pathogens 
(Gulig et al. 2008). This review will focus on methods that have been developed for bacterial 
detection using phage reporters; specifically those that utilize phage display technologies.  
Bacteriophage-based detection strategies are generally quicker than many antisera/antibody 
methods, offering results typically in days as compared to months by conventional methods. 
Phage typing has been most extensively used for the detection of Mycobacterium, 
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Escherichia, Pseudomonas, Salmonella and Campylobacter species (Barry et al. 1996). 
Developing phage reagents is also quite simple, rapid, economical and easy to manipulate 
genetically. There is a considerable amount of literature from investigations that use phage 
display methods for the detection of a variety of antigens for a variety of purposes. We will 
highlight those that contribute a novel aspect to the use of phage display for bacterial 
detection purposes. The specificity of bacteriophage for bacterial cells enables them to be 
easily used for the typing of bacterial strains and pathogens. This natural specificity can be 
improved by phage displaying targeting peptides on the capsid surface. The most commonly 
used antibody for this is the single chain F variable (scFv) portion that contains the antigen 
binding regions of the heavy and light chains; an antibody portion can normally be obtained 
from animals that are immunized with the target antigen/microbe. Phage particles that 
display the fusion peptide of interest are then selected by a process called “panning”, which 
involves the binding of phage to the antigen, the subsequent washing away of unbound 
phage, and finally the eluting of bound phage followed by amplification in the appropriate 
host cell (Smith 1985; Gulig et al. 2008). Unbound scFv is normally unsuccessful for the 
purposes of bacterial detection.  
 Sorokulova et al. (2005) developed a random 8-mer landscape phage library expressing 
fusions to coat protein (pVIII) of fd phage. The phage were panned against S. typhimurium 
whole cells resulting in the isolation of a phage that was highly specific towards Salmonella 
whole cells (Sorokulova et al. 2005).  In a follow-up study, Olsen et al. (2006) were able to 
detect Salmonella with this phage at titers as low as 100 cells/mL (Olsen et al. 2006).  This 
technique was also used to pan against Bacillus anthracis, an organism of particular 
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importance in thwarting bioterrorist threats, leading to the identification of multiple phage 
with the ability to capture anthrax spores with reasonable specificity (Brigati et al. 2004).   
Ide et al. (2003) used the New England Biolabs 12-mer library of random peptides in an 
effort to isolate peptides for the identification of the H7 flagella of E. coli O157:H7 
(Enterohemorrhagic E. coli, or EHEC). This is a pathogenic strain of bacteria that is 
responsible for the onset of hemorrhagic colitis and hemolytic uremic syndrome (HUS), due 
to the release of phage-encoded Shiga toxin (H7 antigen) that is shared by most strains and 
encoded by the resident prophage, 933W.  They were able to develop specific clones to H7, 
one of which could bind to intact E. coli cells expressing flagella (Ide et al. 2003).  Similarly, 
Turnbough et al. (2003) developed phage libraries using New England Biolabs 7- and 12-mer 
libraries to isolate phage clones that could recognize a variety of Bacillus spores, including 
those formed by B. anthracis species. They were also able to differentiate between the spore 
types, an important aspect in the development of anti-spore reagents (Turnbough 2003).  
Phage can also be used to deliver reporter genes such as GFP that are expressed upon 
infection of a bacterium (Loessner et al. 1997; Funatsu et al. 2002).  Funatsu et al. (2002) 
manipulated λ by direct cloning to express a GFP reporter gene.  The researchers were able 
to detect an E. coli infection four to six hours post-infection, using fluorescent microscopy to 
detect fluorescing bacteria (Funatsu et al. 2002). In a similar study by Oda et al. (2004), 
virulent phage PP01 specific to E. coli O157:H7 was used. Here, The GFP gene was 
displayed on the surface of the Soc capsid protein without compromising the phage host 
range. Visual detection of infected target cells was again accomplished by fluorescent 
microscopy after an incubation time of only 10 minutes. The test worked on viable cells, 
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viable but non-culturable, and most notably dead cells, although with a far lower 
fluorescence level (Oda et al. 2004).  The same group constructed a T4-based reporter phage 
possessing a GFP fusion to the Soc protein of the capsid. This phage mutant was deficient in 
the ability to produce T4 lysozyme at the end of its replication cycle, thereby trapping the 
reporter phage within the target cells. Detection and visualization of the targeted cells was 
relatively efficient as GFP continued to accumulate within (Tanji et al. 2004).  
Future applications of phage display to bacterial detection will likely look into the 
development and utilization of new non-immunoglobulin target-binding tools that can be 
engineered to increase the randomness of binding. For example: i) affibodies that are small 
proteins isolated from Staphylococcus aureus protein A can be manipulated by randomizing 
the 13 a.a. binding domain and highly specific affibodies to protphageein targets have 
already been obtained; and ii) anticalins that are proteins based on lipocalin proteins that 
transport or store molecules that are soluble and can be manipulated to recognize a variety of 
targets with high affinity binding (Gulig et al. 2008).  
1.6.4 Phage as Bio-control Agents  
Expanding on the concept of bacterial detection, phage products can also be manipulated to 
recognize and clear bacterial infections. Typical phage based bio-control procedures include 
the use of purified lytic enzymes from phage (Fischetti 2005), while other approaches 
employ genetically modified phage to not lyse cells, but rather to serve as targeted delivery 
vehicles for DNA encoding antibacterials, to targeted pathogens (Westwater et al. 2003). 
Particulate phage are relatively easy and inexpensive to purify, and phage display can also 
serve as an economical means to purify a particular protein/antibody (Clark & March 2006). 
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Phage display libraries can easily be screened against a set of target proteins with affinities 
similar to antibodies, which can then be used as therapeutic agonists or conversely, inhibitors 
of receptor-ligand interactions (Clark & March 2006). As an added advantage, the generation 
of phage display antibodies does not require the use of animals when working with existing 
libraries, eliminating the need to inoculate animals with often toxic substances or highly 
lethal infectious agents that increase costs and production times (Gulig et al. 2008). Phage 
display methods can also be performed in vitro from randomly generated a.a. sequences or 
randomly assorted antibody fragments, where the agents can be used directly to determine 
the detection efficiency (Gulig et al. 2008).  
Finally, phage can be used to bind specifically to released components within circulation, 
including toxins, and bacterial pathogens to prevent them from harming the host (Petrenko & 
Vodyanoy 2003). An especially novel use of phage display was the nasal administration of 
phage displaying antibodies against cocaine as a treatment against cocaine addiction 
(Dickerson et al. (2005). The whole filamentous phage particles were able to effectively 
cross the blood-brain barrier and penetrate the central nervous system where the specific 
phage displayed antibodies could bind cocaine molecules, thereby preventing the behavioral 
effects from the drug (Dickerson et al. 2005). 
Phage-based techniques for the control of bacterial pathogens have undergone a great deal of 
research to date where these methods offer a set of advantages over conventional methods of 
detection, particularly when considering time and specificity. Furthermore, many of the 
outlined methods feature high sensitivity and can be offered at relatively low cost. Following 
administration, phage dissipate rapidly throughout the mammal and reach the organs at 
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varying rates and to varying degrees (Dabrowska et al. 2005). While this is an advantage for 
detection and treatment purposes it also means that phage are cleared quickly by the immune 
system and as strong immunogens, are targets of antibody neutralization and clearance. 
While phage offer promising alternatives for therapeutic uses, the physicochemical 
characteristics that make them highly immunogenic, limits their utility as repetitive 
therapeutics (reviewed in Kaur et al. 2012).  
1.7 Summary 
With an estimated 1031 phage particles worldwide (Gulig et al. 2008), bacteriophage offer a 
practically unlimited reservoir of exploitable genetic information that can be applied to a 
plethora of purposes. The applications of phage display are many and the rich and growing 
research in this area suggests a promising future for their exploitation in medicine, food 
science, biotechnology and nanotechnology, just to name a few.  
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Chapter 2 : Rationale, Hypothesis and Objectives 
 
2 Rationale, Hypothesis and Objectives  
 
2.1 Rationale 
2.1.1 C-terminal eGFP fusions on λ 
Bacteriophage  λF7 (λDam15imm21cIts) was selected as an amber mutant for the gpD gene, 
whereby the phage develops an immature head lacking gpD that renders it extremely 
sensitive to EDTA among other irritants and requires external sources of gpD to confer a 
stable phage capsid head (Sternberg et al. 1979).  In this study, C-terminal fusions of gpD 
were supplied via a 2-dimensional expression system using:  
a) The construction of the fusion plasmid pPL451-gpD::eGFP (herein referred to as 
pD::eGFP). The plasmid was incorporated into high-copy number plasmid vector 
pPL451 under the control of temperature sensitive repressor, CI857.  
b) Amber suppressor strains of E. coli which act to read-through the UAG stop codon 
and insert a particular (and varied depending on the Sup+ strain) a.a. in its place to 
allow for the expression full-length wild type alleles of gpD.  
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2.1.2 Temperature-Inducible control of fusion capsid decoration: 
2.1.2.1 First dimension of control - Regulation of D::eGFP expression via the 
CI[Ts]857 Repressor: 
 
The fusion protein in plasmid pPL451 is under the control of the temperature-sensitive  
repressor mutant allele, CI857, which acts from λ OR and OL operator sites in vivo to prevent 
transcription of prophage genes at low temperatures (<35˚C). Phage λ undergoes induction at 
higher temperatures where the repressor is inactivated, allowing the development of phage 
progeny (Figure 10/ Figure 11).  In this study, the fusion protein plasmid pPL451 is regulated 
by a temperature-controlled expression system with CI857 such that:   
a) At high temperatures (>35oC) there is a decrease in CI857 repressor activity 
permitting the expression of D::eGFP fusion from the pPL451 plasmid. This will be 
seen as both an increase in complementation and an increase in eGFP expression.  
b) At low temperatures (<35oC) the CI857 repressor is active and D::eGFP fusion from 
the pPL451 plasmid is not expressed resulting in decreased gpD::eGFP 
complementation for the D— mutation, and minimal eGFP  decoration and activity 
as compared to higher inducing temperatures.  
 
Figure 10: C1857 repressor activity. The λ 
CI857 repressor maintains the prophage state 
of the virus at low temperatures by regulating 
expression via occupation of the λ OL and OR 
operator sites that govern expression of all 
lytic phage genes (Ptashne 2004). 
 39   
 
The λ cI gene codes for a repressor that maintains the lysogenic state of the phage. In this 
study, λDam15imm21cIts (λF7) was chosen as a λ phage hybrid with the immunity (imm) 
region derived from a closely related, but heteroimmune, lambdoid phage (phage 21) in place 
of the λ imm region, and the remainder of the phage genome derived from λ. Although the λ 
repressor binds its own operator sites, this hybrid phage possesses the operator sites of phage 
21 and is thereby heteroimmune and not regulated by λ CI.  
30 31 32 33 34 34.5 35 35.5 36 36.5 37 37.5 38 38.5 39 39.5
D
::
e
G
FP
 In
co
rp
o
ra
ti
o
n
 
Temperature (˚C)
Efficiency of D::eGFP Incorporation 
 
Figure 11: Hypothetical efficiency of gpD::eGFP incorporation with pPL451 
gpD::eGFP. The fusion protein is under temperature control where at 35˚C, we will begin to 
see the derepression of the pPL451 plasmid and with that increasing incorporation of gpD::X 
fusions per λ phage capsid, maximized at 405 to 420 possible incorporations per capsid. 
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2.1.2.2 Second-Level of Control—Amber suppression and the generation of 
different alleles of gpD: 
The phage employed in this work is the λ amber mutant, λDam15imm21cIts, or λF7. This 
phage encodes an amber (UAG) mutation at the 68th a.a. position of D that imparts the early 
termination of the translation of the D transcript. In wild-type (suppressor-negative, or Sup-) 
E. coli hosts, the Dam15 yields terminated translation and the generation of a 67 a.a. 
truncated gpD product, precluding the ability of F7 phage to form stable capsids necessary 
to produce viable progeny.  The fusion plasmid (pPL451 gpD::eGFP) encodes the D::eGFP 
fusion, thereby providing the only source of functional gpD in Sup- cells to be incorporated 
into the phage capsid.   
 E. coli amber suppressor (Sup+) strains permit the full translation of Dam15 transcripts and 
allow for the formation of various full length gpD capsid protein as each amber suppressor 
encodes a different mutated tRNA gene that reads the UAG stop codon and inserts a residue 
in its stead (Figure 12). The double amber suppressor, BB4 (supE, supF), can yield 
functional λF7 phage particles in the absence of the fusion plasmid and thus can serve as a 
positive control for phage efficiency of plating, as well as a negative control for eGFP 
decoration. Amber suppressor strains W3101 SupD (serU132), W3101 SupE (glnV44) and 
W3101 SupF (tyrT5888) insert amino acids serine, glutamine and tyrosine in place of the 
amber stop codon and conferring alleles gpDQ68S, gpDwt and gpDQ68Y, respectively. We 
hypothesized that suppressor SupE, yielding gpDwt would confer the strongest suppression as 
it restores the pristine gpD sequence. SupD and SupF were hypothesized to develop alleles of 
gpD that would be less stable, and therefore less favourable for capsid head development.  
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Figure 12: Amber suppressor strains. The amber suppressors act on the stop codon (UAG) 
in the sequence of the phage gene for gpD and use a tRNA which substitutes an a.a. for the 
stop codon resulting in the full translation of wild-type alleles of gpD. Strains that do not 
contain an amber suppressor mutation will end up with a 67 a.a. truncated gpD protein due to 
translational stop at the 68th position translational stop encoded by the amber mutation.   
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2.2 Hypothesis  
By varying the temperature and the level of suppression of λF7 (λDam15imm21cIts) phage 
grown in an E. coli host species, the number of gpD::X fusions decorating phage  can be 
varied in a predictable and consistent manner, whereby the degree of decoration will depend 
on the size of the intracellular fusion protein pool available, and the functionality of the 
various full length alleles of gpD present. This will be seen across two levels of control, 
where:  
a) Raising the temperature will result in an increasing incorporation of gpD::X fusions 
per λ phage capsid 
b) There will be a functional variance amongst the full length gpD alleles where the 
structural functionality of alleles will be inversely proportional to the number of 
fusion decorations on the phage capsid.  
c) The combination of the genetic control mechanisms will permit a robust spectrum of 
gpD::X decorative permutations on average per  phage capsid. 
2.3 Objectives  
The objectives of this research address the bacterial and bacteriophage preparations as 
characterization of the preparation permutations:  
1. To prepare phage samples under various temperature and isogenic suppressor 
conditions, generating a robust sample set to assess regulate adjustability of fusion 
decoration. 
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2. To determine the ability of various gpD alleles and fusions to complement for the 
Dam15 mutation, as a measurement of phage viability.  
3. To determine the average number of gpD::eGFP peptides/phage capsid under each set 
of these conditions. To determine the relative size and the surface complexity of the 
phage preparations under each condition.  
4. To assess phage stability of the phage fusion preparations, under each set of 
conditions.  
A diagram of the combination of the levels of control can be found in Figure 13 (below).   
Figure 13: The dual expression system. The combination of the genetic control 
mechanisms will permit the availability of both gpD and fusion protein D::eGFP within the 
cell to decorate the phage capsid head.  The fusion protein is under temperature control, such 
that an increase in temperature will result in an increasing incorporation of gpD::X fusions 
per λ phage capsid. Each full length gpD allele, different for each suppressor strain, will vary 
in its functionality and this functionality will be inversely proportional to the number of 
gpD::eGFP fusions averaged per phage capsid.  
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Chapter 3 : Materials and Methods 
3 Materials and Methods  
3.1 Buffers and solutions 
Ampicillin Stock (Sigma Aldrich, Oakville, Canada) 
Purpose: A selective marker necessary for plasmid amplification and maintenance of pPL451 
and derivative plasmids in E. coli hosts. . 
Prepared at a concentration of 50mg/mL by dissolving ampicillin stock powder into sterile 
water and filter sterilized. 
Stored at -20º C; thawed solution was added to media as necessary to final concentration of 
100 μg/ml. 
Luria Bertani (LB; BD Difco, Mississauga, Canada) Broth 
Purpose: a nutrient-rich broth used for the rapid growth of bacteria cultures in culture. 
1L ddH2O added to: 10g Tryptone, 5g Yeast abstract, 5g NaCl. 
Antibiotic was added as needed to agar after autoclaving.  
Stored at room temperature (4˚C if antibiotic added)  
LB Agar (BD Difco, Mississauga, Canada) 
Purpose: Used for the growth of bacterial cultures on semi-solid media (plating) 
1L ddH2O added to: 10g Tryptone, 5g Yeast abstract, 5g NaCl, 13g bacto agar 
Antibiotic was added as needed to agar after autoclaving. Autoclaved media was poured to 
sterile monoplates and stored at 4˚ C. 
LB Top Agar (BD Difco, Mississauga, Canada) 
Purpose: Used for the even dispersion of bacterial growth cultures as a plate overlay. 
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1L ddH2O added to: 10g Tryptone, 5g Yeast abstract, 5g NaCl, 7g bacto agar 
Aliquots were dispersed into bottles then autoclaved as necessary and stored in 52˚ C water 
bath. 
PEG (Polyethylene Glycol) (Sigma Aldrich, Oakville, Canada) 
Purpose: used for phage concentration and purification. 
1L ddH2O added to:  0.2 M PEG 8000, 0.15 M NaCl and filter sterilized.  
TN Buffer (Fisher Scientific, Ottawa, Canada)  
Purpose: used for phage dilutions and storage. 
1L ddH2O added to: 0.1 M NaCl, 0.01 M Tris-HCl, pH adjusted to 7.8 and stored at room 
temperature after autoclaving.  
TN/EDTA Buffer (Fisher Scientific, Ottawa, Canada) 
Purpose: used for phage EDTA sensitivity testing.  
1L ddH2O added to: 0.1 M NaCl, 0.01 M Tris-HCl, pH adjusted to 7.8 + 0.1 M EDTA and 
stored at room temperature after autoclaving.  
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3.2 Strains and plasmids 
Strains of bacteria, phage and plasmids used in this work are shown in Table 1.  
Table 1: Summary of Bacteria, phage and plasmids in this study 
Cell/Phage/Plasmid 
Designation 
Genotype Source/Reference 
Bacterial Strains   
BB4 supF58 supE44 hsdR514 galK2 galT22   
trpR55 metB1 tonA DE(lac) U169 
Agilent Technologies, Inc. 
W3101 F-, galT22, λ-, IN(rrnD-rrnE)1, rph-1 CGSC #4467 
Bachmann (1972) 
W3101 SupD F-, galT22, λ-, IN(rrnD-rrnE)1, rph-1, 
uvrC279::Tn10, serU132(AS), 
Nicastro et al. (2013)  
W3101 SupE F-, galT22, λ-, IN(rrnD-rrnE)1, rph-1, 
crcA280::Tn10, glnV44(AS), 
Nicastro et al. (2013)  
W3101 SupF F-, galT22, λ-, IN(rrnD-rrnE)1, rph-1, 
oppC506::Tn10, tyrT5888(AS) 
Nicastro et al. (2013)  
Phage Strains   
λimm21 λimm21cIts Windass & Brammar (1979)  
λF7 λDam15imm21cIts Mikawa et al. (1996) 
Maruyama et al. (1994) 
Plasmids   
pPL451 pM-cI857-pL-cI857-pL-MCS-tL National BioResource 
Project (NBRP); 
pPL451 gpD pM-cI857-pL-cI857-pL- D-tL Sokolenko et al. (2012) 
pPL451 gpD::eGFP pM-cI857-pL-cI857-pL- D::gfp-tL Sokolenko et al. (2012) 
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3.2.1 Bacterial Strains 
BB4 (supF58 supE44 hsdR514 galK2 galT22 trpR55 metB1 tonA DE(lac) U169) was utilized 
as a positive control as the baseline for the determination of the efficiency of plating (EOP) 
of each of the amber mutant phage (F7) samples. BB4 served as the 100% plating efficiency 
standard from the action of dual amber suppression (supE and supF) encoded by this strain.  
Plating efficiency of the λDam15 mutant on this strain is comparable to that of the wt 
λimm21 phage. 
W3101 served as the negative control for λDam15 plating efficiency (EOP) as well as the 
host strain of the negative control phage (F7) sample. This strain is free of an amber 
suppressor (Sup—) λDam15 is phenotypically D— on this host and inviable. 
Isogenic suppressor (Sup+) strains of W3101 (F-, galT22, λ-, IN(rrnD-rrnE)1, rph-1) were 
previously constructed in our lab in two steps (Sheldon 2013).  First, P1 rev6-mediated 
transduction of a tetracycline resistance (TcR) marker from CAG12077 to recipient amber 
suppressor (AS) strains DS-3 (F-, phoA4(Am), serU132(AS), his-45, rpsL114(strR), 
valR116), and W3899 (F-, glnV44(AS), nadB7) was performed to link the AS marker to the 
TcR marker. K1227 (SupF) already possessed a linked TcR marker (see Table 1). P1 rev6 was 
used to co-transduce the AS and TcR marker (<2 min distance) into recipient W3101 cells, 
which were screened with λDam15imm21cIts (λF7) and λSam7 phage to ensure transfer of 
the AS alleles, respectively linked to the TcR marker, derived from donor strains, to the 
W3101 non-suppressor (Sup—) recipient strain.  The amber suppressor mutants used in this 
study were:  W3101 SupD (serU132), W3101 SupE (glnV44) and W3101 SupF (tyrT5888).  
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3.2.2 Phage Strains 
λF7 (λDam15imm21cIts) was used as the lambda D amber mutant phage which is unable to 
form viable phage particles in the absence of amber (UAG) stop codon suppression at 
position 68 of the 110 a.a. protein. The viability, stability and analysis of capsid fusions were 
all studies on this phage under a variety of conditions.  
λimm21 (λimm21cIts) was used as a control for sizing experiments with dynamic light 
scattering. This phage is structurally and genetically identical to wild-type phage λ except for 
the immunity which has been recombined with the immunity region of phage 21.  
3.2.3 Plasmids Used  
pPL451-gpD::eGFP (pD::eGFP) involved the gpD::eGFP expression from this multicopy 
plasmid (pPL451; Figure 14) governed by a temperature-sensitive allele of the λ CI857 
repressor. The D::eGFP sequence designed creates a C-terminal eGFP translational fusion 
with  D capsid gene, separated by an in-frame short linker a.a. p(TSGSGSGSGSGT) 
followed by a KpnI cut site to allow for removal and exchange of eGFP.  
Plasmid pPL451-gpD (pD) was constructed by digesting pPL451-gpD::eGFP by KpnI 
removing all but the last 30 C-terminal bp of eGFP. Plasmid pPL451 was digested with HpaI 
and pPL451 gpD::eGFP and pPL451 gpD were double digested with HpaI and NcoI and the 
digestion pattern was analyzed to ensure cloning accuracy. 
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Figure 14: Plasmid pPL451. This 4.249 kb temperature regulated expression vector is 
driven by λ PL promoter under the control of the temperature-sensitive CI857 repressor 
encoded by the cI857 gene that stimulates its own expression.  
 
3.3 Lysate Preparation and Amplification 
Cultures of transformed W3101 Sup+/Sup— [pPL451-gpD::eGFP] (pD::eGFP) E. coli cells 
were grown on plates at 30, 35, 37 or 39°C overnight, while cultures of W3101 [pPL451-
gpD] (pD) were grown up at 37°C only, prior to the addition of primary lysate dilutions. 1:10 
dilutions of primary lysates were prepared in 1 mL of TN buffer (0.01 M Tris-HCl and 0.1 M 
NaCl, pH 7.8, (Fisher Scientific, USA). Lysate dilutions were added to 0.3 ml of cells, 
incubated for 2 h at experimental temperature prior to adding 3 ml of top agar (Bacto 
Tryptone and Bacto Agar from Difco Laboratories, Sparks, MD) and plates were incubated 
overnight at the experimental temperature. Plate lysates were then prepared by adding 10 mL 
of TN buffer to the surface of the plate, incubating for 8 h at 4°C, then transferring solution 
and top agar to a conical tube, mixing and centrifuging at 12 K RPM (Avanti J-E Centrifuge, 
Beckman Coulter, Mississauga Canada) at 4°C for 20 min.  
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3.4 Phage Purification  
To remove cellular debris, lysates were then filtered through a sterile 0.45 m syringe filter 
(BD Discardit, India). To purify lysates from unincorporated fusion and other cellular 
proteins, particularly unincorporated gpD::eGFP, lysates were purified as previously 
described by PEG precipitation and gel chromatography offering lysate purity comparable to 
that of CsCl centrifugation and amenable to lysate smaller volumes (Zakharova et al. 2005).  
Lysates were concentrated through PEG precipitation, as previously described (Baker 
Laboratory 1999), then  disseminated through a 50-150 L agarose size exclusion column 
(4% beads, ABT, Spain) in buffer containing 10 mM Tris-HCl (pH 7.5) and 1 mM MgCl2. 
Samples were stored at 4ºC. 
3.5 Phage Titration and Efficiency of Plating Assays 
Phage were titered at each step of purification by standard viability assays by standard plaque 
forming unit assay using fresh BB4 E. coli cells  as the 100% control, as this strain 
repeatedly generates highest titers of λF7 ranging from 1010 to 1012 phage/ml.  Plates were 
incubated overnight at experimental temperature when necessary, otherwise, at 37oC. 
Relative EOPs  at all test temperatures were determined as phage plating efficiency on the 
experimental strain divided by that scored on the BB4 100% control.  
3.6 Dynamic Light Scattering of Phage 
Phage particle size was measured at 25oC using a Malvern Zetasizer Nano ZS instrument 
(Malvern instruments, UK). Samples were prepared in Milli-Q water and filtered using a 100 
nm filter prior to measurement.  The measured sizes are reported using a percent intensity 
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distribution.  Each data point was automatically repeated in triplicate, and the average was 
reported. Sizing results are expressed based on “X” increase compared to wild type, which is 
λDam15imm21cIts (λF7) grown on the BB4 providing suppressed dual gpDwt and 
gpDQ68Yincorporation into the resultant phage capsid. 
3.7 Whole Phage Fluorimetric Analysis 
Phage samples were prepared in TN buffer by diluting each sample to a uniform 
concentration of 2.0 x 109 PFU/mL. 150 µL of each prepared sample was then added to a 
sterile 96 well plate (Starstedt) and were analyzed using a SpectraMax M5 spectrophotometer 
at an excitation of 485 nm and an emission of 555 nm. The data was analyzed using the 
SoftMaxPro V5 software where each well was set to be automatically read 6X and the 
samples were run in duplicate with the average being reported. Phage samples were run 
alongside an eGFP purified protein standard (Cell Biolabs Inc. #212103) to determine the 
protein concentrations of each sample.  Phage fluorescence for each preparation derivative 
was interpolated from the trend-line for known eGFP concentrations and the standard error 
was determined by finding the error associated with this interpolation. The standard error of 
each of the sample fluorescence values was determined in a weighted analysis against the 
determination of the sum of the squares of the fluorescence based deviations from the trend-
line curve of the fluorescent standard. The standard deviation of each sample was not taken 
into consideration in the calculations as these deviations were determined to be statistically 
less significant than the determination from the interpolation itself. 
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3.8 Flow cytometry analysis 
 Fluorescence and side scatter measurements of phage samples were determined on a 
FACSCalibur flow cytometer (BD Biosciences, San Jose, CA) as described by Sokolenko et 
al. (2012). Briefly, the flow cytometer was equipped with a 15 mW air-cooled argon-ion 
laser, with an excitation frequency of 488 nm. Side scatter (SSC) and Fluorescence (FL) 
photomultiplier tube (PMT) voltages were set to 500 V and 525 V, respectively, with 
logarithmic amplification. A 530/30 nm bandpass filter was used for the observation of 
D::eGFP fluorescence. All samples were serially diluted 1X, 10X, and 100X using 
phosphate buffer saline (PBS) and run for 30 s at the low flow setting (20 L/min). The 
dilutions were used to assess instances of “coincidence”, where a high sample concentration 
results in multiple particles being observed as a single event. Data analysis was conducted by 
Stanislav Sokolenko (UW, Chemical Engineering) as described in Sokolenko et al. (2012). 
3.9 EDTA sensitivity 
Phage were diluted in TN buffer (0.01 M Tris-HCl and 0.1 M NaCl, pH 7.8) (Fisher 
Scientific, USA) to a universal concentration of 4.0 x 108 PFU/mL, then were diluted 100-
fold into TN/EDTA buffer (0.01 M Tris-HCl (pH7.8), 0.1 M NaCl, and 0.01M EDTA) and 
incubated for 25 min at 23oC. EDTA inactivation was stopped by diluting the samples 100-
fold into TN buffer and immediately plating the mixture on BB4 cells (SupE, SupF).  Plates 
were incubated overnight at 37oC. Relative plating efficiency of each sample was determined 
by measuring phage relative plating efficiency divided by the original phage titer as the 
100% positive plating control.  
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Chapter 4 : Results 
 
4 Results 
4.1 Suppressor conferred alleles  
To identify the ability of different amber suppressors to reverse the F7 (λDam15imm21cIts) 
lethal Dam15 mutation, an isogenic set of amber suppressor derivatives of W3101 (Sup—) 
was generated and the plating efficiency of F7 was assayed on each suppressor host strain 
(Table 2).   Of the three different gpD alleles generated via suppression, gpDQ68S, generated 
by the SupD host, was least effective in complementing the Dam15 mutation and improved 
viability by only 10-fold compared to that of the Sup— control at 37oC. In addition this allele 
imparted pinpoint plaques on the SupD strain, indicative of a very low burst size of viable 
progeny. In contrast, the gpDwt allele, conferred by the SupE strain, restored viability to 
about 10% that of the double suppressor (SupE, SupF) positive (designated 100% plating) 
control. The gpDQ68Y allele, imparted by the SupF strain, also surprisingly performed as 
well, if not marginally better than SupE in an otherwise isogenic host background. The 
gpDQ68Y allele restored viability to about 20% that of the positive control, despite the size 
and polarity difference between glutamine (SupE) and tyrosine (SupF). These results were 
corroborated by the efficiency of plating (EOP) on hosts  carrying the parent (backbone) 
plasmid, pPL451, indicating that suppressor capability was not dramatically impacted by 
differences in temperature, nor by the presence of the CI857 repressor (Table 2). 
 54   
 
Next, we sought to determine the ability of the pD and pD::eGFP plasmids to complement 
for the Dam15 mutation of F7. The expression of the D allele or D::eGFP fusion in these 
plasmids, respectively, is governed by the temperature sensitive λ CI857 repressor. First, the 
non-suppressor strain W3101 was transformed by pD and pD::eGFP, assuming that the 
ability to properly package and produce viable λDam15 particles would rely solely upon in 
trans complementation for the Dam15 mutation from the plasmid. As expected, at increasing 
temperatures, complementation for Dam15 by plasmid-borne D (pD) increased as repressor 
activity decreased, with optimal results seen at 39oC, where near full viability of λDam15 
was restored (Table 2). The lack of complementation by pD at 30oC resembled that of 
pPL451 (D—), indicating strong repression and insignificant promoter leakiness. The 
experimental plasmid expressing D::eGFP also showed a temperature-governed 
complementation profile that paralleled that of the pD plasmid, despite that viability was 
about 10-fold lower at all assayed temperatures, where optimal complementation was 
achieved again at 39-40oC. In contrast, as expected, the D— parent plasmid (pPL451) was 
unable to complement for the mutation at any tested temperature. 
Complementation for the Dam15 mutation by the gpD and gpD::eGFP plasmids could not be 
differentiated from suppression of the mutation on SupE (gpDwt) and SupF (gpDQD68Y) 
hosts carrying the plasmid due to strong suppressor activity by these strains at all 
temperatures. However, due to the low viability of λDam15 on the SupD derivative, 
complementation by gpD::eGFP was observable as expression of the fusion increased with 
rising temperature and like the Sup—[pD::eGFP] strain, SupD[pD::eGFP] provided the 
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greatest and a similar level of complementation for the Dam15 mutation at 39-40oC. Plaques 
also were observed to increase from pinpoint to wild type  plaques on this host. 
Table 2: Variable amber suppression and complementation of the Dam15 mutation 
Strain 1 / 
Plasmid 2 
Relative efficiency of plating (EOP) 3  
30o C 32-33 o C 35 o C 37 o C 39-40 o C 
Sup-    
   pD— 
   pD+ 
   pD::eGFP 
--- 
4.06 x 10-6 
7.5 x 10-6 
7.5 x 10-6 
--- 
5.0 x 10-6 
3.2 x 10-5 
2.0 x 10-5 
--- 
3.1x 10-6 
2.1 x 10-4 
2.0 x 10-5 
1.92 x 10-6 
1.7 x 10-6 
0.15 
0.02 
--- 
2.0 x 10-6 
0.93 
0.01 
SupD 
   pD— 
   pD::eGFP 
--- 
8.8 x 10-5 
4.9 x 10-5 
--- 
6.5 x 10-5 
1.8 x 10-5  
--- 
1.5 x 10-5 
8.0 x 10-5  
1.13 x 10-5 
9.5 x 10-6 
0.09 
--- 
2.3 x 10-5 
0.05 
SupE 
   pD— 
   pD::eGFP 
--- 
0.04 
0.1 
--- 
0.11 
0.04 
--- 
0.07 
0.02 
0.09 
0.03 
0.07 
--- 
0.08 
0.03 
SupF 
   pD— 
--- 
0.01 
--- 
0.01 
--- 
0.04 
0.19 
0.04 
--- 
0.03 
   pD::eGFP 0.1 0.13 0.06 0.07 0.05 
 
1 Derivatives are W3101 background. 
2 Derivatives of CI857 temperature-regulated expression plasmid, pPL451. 
3 All EOP determinations are averaged from a minimum of three assay and determined using 
BB4 (SupE, SupF) as the designated full (100%) plating control.  
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4.2 Fluorimetric Analysis of gpD::eGFP decorated phage 
λDam15 phage were variably decorated with gpD::eGFP by passaging through the Sup— and 
Sup+ strains carrying the pD::eGFP plasmid at various temperatures. All lysates were 
standardized for titer before being assayed for functional fluorescence by fluorimetry. 
Emitted fluorescence from 108 phage from each lysate was interpolated against an eGFP 
standard of known concentration, and the average number of eGFP fusions per phage was 
then determined (Table 3/ Figure 15). Due to the expected lack of production of a functional 
gpD allele from either the phage or the plasmid at 30oC in Sup— [pD::eGFP], no progeny can 
be formed and as such lysates could not be generated under this condition. Upon raising the 
temperature to >35oC, the D::eGFP fusion was expressed to yield some viable phage and to 
produce a lysate. Decoration of phage by eGFP was increasingly evident with rising 
temperature (derepressing expression of pD::eGFP) above 35oC, with greatest fluorescence 
observed at 37oC. All lysate preparations similarly showed increases in fluorescence up to 
37oC, albeit considerably lower for phage prepared on the strong suppressor strains, SupE 
and SupF. This finding is attributable to the preferential packaging of gpDwt or gpDQ68Y 
alleles compared to gpD::eGFP fusion proteins during phage capsid assembly. In contrast, 
lysates prepared on SupD, offering the weakest gpDQ68S suppressor, imparted the strongest 
fluorescence signal from all preparations, with minor but notable fluorescence even at 30oC. 
The signal observed at this temperature suggests that some leaky expression of pD::eGFP 
from the plasmid must occur under repressing conditions (30o), but more importantly 
demonstrates the strong ability of gpD::eGFP to complement Dam15 in the presence of the 
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poorly functional gpDQ68Y protein. We noted quite high variability between readings for 
SupD prepared lysates at most temperatures, suggesting that despite generating the highest 
possible incorporation of gpD::eGFP into the phage, decoration between phage prepared on 
this strain are inconsistent, or may result in multiple preferred decorative species. We discuss 
and offer an explanation for this finding below.  
Interestingly, lysates prepared at 39-40oC on all strains offered decreased fluorescence 
compared to those prepared at 37oC on all Sup+ and Sup— strains, despite that derepression of 
pD::eGFP at this temperature is complete and offered highest complementation efficiency 
for the Dam15 mutation. To further investigate this finding and determine whether this is due 
to diminished activity of eGFP at 40oC, or rather decreased integration of gpD::eGFP into the 
phage capsid, we next sought to examine the size of resultant decorated phage. 
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Table 3: Estimated average eGFP molecules per phage 
Strain (+/- Plasmid) 1 Estimated eGFP/phage 2  
30oC 35oC 37oC 39oC 
Sup— [pD::eGFP] n/a 44 ± 4 115 ± 4 61 ± 4 
SupD  [pD::eGFP] 86 ± 4 127 ± 4 147 ± 4 142 ± 4 
SupE  [pD::eGFP] 46 ± 4 53 ± 4 77 ± 4 69 ± 4 
SupF  [pD::eGFP] 65 ± 4 69 ± 4 89 ± 4 69 ± 4 
1 all strains are derivatives of W3101. 
2 fluorescence measurements were divided by those derived from λF7 grown on that strain. 
Values in parentheses denote calculated number of functional eGFP fusions per phage 
interpolated from eGFP purified protein fluorescence calibration curve. 
3 Phage preparation on W3101 [pD] at 37oC expressing gpDwt in trans 
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Figure 15: Separation of decorated lysate preparations based on fluorescence emitted. 
Fluorescence ratios based on comparison to λF7 (Dam15) grown on W3101 SupE 
[pD::eGFP]. Measured fluorescence data was analyzed using the SoftMaxPro V5 software 
based on 6 readings and the samples were run in duplicate with the average being reported. 
Phage samples were run alongside an eGFP standard to determine the protein concentrations 
of each sample.  Phage fluorescence for each preparation derivative was interpolated from 
the trend line for known eGFP concentrations. The data was corrected against the W3101 
Sup— [pD] negative control where the difference of this fluorescent data point was subtracted 
from each sample. The data was corrected against the W3101 sup- [pD] negative control 
where the difference of this fluorescent data point was subtracted from each sample. 
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4.3 Size comparisons of gpD::eGFP decorated phage 
Lysates prepared on the Sup series at experimental temperatures were standardized for titer 
and then sized by dynamic light scattering (DLS) to approximate relative size differences 
between undecorated and decorated fusion (gpD::eGFP) displaying phage (Figure 16). The 
size determinations for λDam15imm21cIts (F7) phage grown on SupE, (gpDwt), compared 
well to that of λimm21 (D+ parent of F7) and was used as the wild type phage size control, 
generating phage with an average diameter of 62 nm.  Relative size differences between 
λDam15 phage grown on the suppressor host series at 37oC in the absence of gpD::eGFP, 
was first determined. As expected, phage grown on Sup— [pD] cells at this inducing 
temperature were similar in size to the control due to efficient complementation, while SupD 
(gpDQ68S) preparations in the absence of pD were surprisingly only about a third the size. 
This finding may suggest that the gpDQ68S allele incorporates very poorly into the capsid, 
resulting in the smaller capsid size. Next, λDam15 phage preparations passaged through the 
suppressors carrying the gpD::eGFP plasmid at various temperatures, were sized by DLS in 
triplicate and compared to the size of the undecorated control phage grown on SupE in the 
absence of pD::eGFP (Table 4/ Figure 16). In all cases, phage size grew as temperature 
incrementally increased up to 37oC, where expression of pD::eGFP was increasingly 
derepressed. Interestingly, phage samples prepared at 39o–40oC, where pD:eGFP expression 
should be maximal, indicated a 30 to 40% decrease in phage diameter compared to that at 
37oC, suggesting that either fewer gpD::eGFP were incorporating into the capsid, despite 
complete derepression of pD::eGFP, or that eGFP were being shed from the decorated 
phage. Phage prepared on SupD [pD::eGFP] at 37o and 39oC were particularly interesting 
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however, as phage samples indicated two notable size peaks, denoting vastly different 
diameters at substantial occurrence; a first peak at ~30 nm and the second at ~280 nm. The 
former size (~30 nm) is similar to that which was seen for λDam15 passaged through the 
SupD strain in absence of plasmid. The very large error in average size determination for 
SupD phage preparations at this temperature can therefore likely be attributed to this bimodal 
size distribution.  
Table 4: Sizing of λDam15 phage variably decorated by gpD::eGFP 
Strain        
[+ Plasmid] 1 
gpD Allele Times (X) increase in phage diameter 2 
30oC 35oC 37oC 39oC 
Sup—    
Sup—   [pD::eGFP] 
gpDwt --- 
n/a 
--- 
2.2 ± 0.5 
1.1 ± 0.2 
5.5 ± 0.8 
--- 
3.5 ± 0.9 
SupD  
SupD  [pD::eGFP] 
gpDwt --- 
0.8 ± 0.1 
--- 
1.2 ± 0.7 
0.3 ± 0.03 
3.1 ± 1.5 
--- 
1.8 ± 0.2 
SupE  
SupE  [pD::eGFP] 
gpDQ68S --- 
0.9 ± 0.2 
--- 
1.0 ± 0.1 
1.0 ± 0.1 
1.7 ± 0.2 
--- 
1.2 ± 0.2 
SupF  
SupF  [pD::eGFP] 
gpDQ68Y --- 
1.0 ± 0.3 
--- 
1.3 ± 0.2  
0.67 ± 0.3 
1.6 ± 0.6 
--- 
1.0 ± 0.3 
1 Lysate produced on strain at respective temp. All strains are derivatives of W3101. 
2 A minimum of three runs of triplicate determinations of size determination from DLS were 
divided by size determinations for naked phage grown on each of the Sup strains. 
Comparisons are for phage grown on SupE in absence of complementation. 
3 Dam15 phage preparation on W3101 [pD] at 37oC, expressing wild type D gene. 
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Figure 16: Sizing of λDam15 phage variably decorated by gpD::eGFP.  Lysates were 
produced on the labelled strain and at the respective temperature, standardized for titer (108 
phage/ml), then sized by dynamic light scattering (DLS). Each size determination was 
repeated in triplicate.  Comparisons are for phage grown on SupE (yielding gpDwt) in the 
absence of complementation, yielding morphologically wild type  phage that were used as 
the control. Each of the reported values represents the relative comparison of the 
experimental phage divided by the control phage size. Phage preparation on W3101 [pD] at 
37oC expressing Dwt in trans are labelled in orange. 
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4.4 Flow cytometry of gpD::eGFP decorated phage 
Lysates prepared on the Sup+ strains at various temperatures were standardized for titer and 
analyzed by flow cytometry. Each sample’s side scatter, which is determined mainly by the 
surface complexity of the phage particle, and fluorescence profile, was found to vary 
between phage preparations and to be influenced by the degree of gpD::eGFP capsid 
decoration. In collaboration with the Dr. Aucoin lab (UW, Chemical Engineering) the use of 
flow cytometry for this application has been previously optimized using phage passaged 
through SupE [pD::eGFP]. After careful deliberation and the trial of many approaches, a 
simple count comparison of fluorescent events was determined to be the most basic and 
useful analysis approach (Figure 17). An overall increase in the count of fluorescent events 
was observed as a function of temperature for all strains. The temperature dependence was 
generally more pronounced between 35o and 37°C than between 30o and 35°C, especially for 
SupD and Sup— preparations, which can be expected since CI857 activity is exponentially 
diminished above 35oC.  For all lysate preparations, the number of fluorescent events evident 
was an order of magnitude higher between 35ºC and 37ºC, in agreement with the CI857 
temperature-lability profile and subsequent expression of gpD::eGFP. Higher culturing 
temperatures corresponded well with expected higher fluorescence up to 37oC due to 
increased gpD::eGFP expression and decoration at this temperature. 
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Figure 17: Mean fluorescent event counts for phage preparations on Sup—, SupD 
(gpDQ68S), SupE (gpDwt) and SupF (gpDQ68Y) strains harbouring the pD::eGFP 
plasmid, cultured at 30o, 35o, 37o, and 39°C. Samples were standardized for titer and 
diluted 10-fold. Fluorescent events are those that had a fluorescence value greater than 1 (the 
logarithmic scale equivalent of 0). Error bars represent 95% confidence intervals around the 
means, calculated from triplicate measurements. In most cases, the error bars are smaller than 
the size of the corresponding data point. Computational and statistical analysis was 
performed by Stan Sokolenko as described in Sokolenko et al. (2012). Figure taken from 
Sokolenko et al. (2012). 
 
Sokolenko et al. (2012) previously demonstrated that 2D fluorescence/side-scatter density is 
a more appropriate visualization tool for discriminating different types of fluorescent events 
between preparations of fluorescence-decorated  phage. Here, we expanded on this 
approach to compare phage preparations on all Sup+ and Sup— strains at all experimental 
temperatures in order to analyze all decoration permutations (Figure 18). We noted that a 
change in temperature from 30o to 35oC corresponded solely to an increase in side-scatter, 
while an increase to 37oC, had a greater impact on event fluorescence, as can be seen in the 
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prominent movement of the main cluster away from the x-axis. The low temperature changes 
in side-scatter can be interpreted as the result of initial capsid modification, with the 
increased expression of D::eGFP at 37oC being required to generate a significant amount of 
fluorescence. Consistent with the event count analysis, strong increases in the fluorescence of 
Dam15 lysates grown on Sup— and SupD strains carrying the pD::eGFP plasmid were noted 
at 37oC, as compared to the comparatively mild increase in fluorescence observed for lysates 
prepared on the strong suppressors, SupE and SupF. While increasing the culturing 
temperature to 39oC did not significantly alter the total number of events detected, it did alter 
the fluorescence distribution across all preparations, most evident in the decrease of 
fluorescence for lysates prepared on the SupD and Sup— [pD::eGFP] strains (Figure 18). The 
impact of increasing the expression of D::eGFP (by increasing the temperature beyond 37ºC 
on the generation of eGFP-tagged phage again appears to be limited. Similar to the results 
obtained for fluorimetry assays, 37oC again was the upper limit for fluorescence, with 
evident reductions in fluorescence at 39-40oC compared to that at 37oC.  
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Figure 18: 2D density distribution of fluorescence vs. side scatter for phage 
preparations on Sup—, SupD, SupE and SupF strains carrying pD::eGFP, cultured at 
30o, 35o, 37o, and 39oC. The density distribution at each temperature is scaled to a constant 
height. Contour lines represent fractions of maximum density (density quantiles ranging from 
0.10 to 0.95 in intervals of 0.05). Events with fluorescence or side scatter values of 1 were 
excluded. Samples were standardized for titer. SupD and Sup— samples cultured at 37°C had 
high concentrations that resulted in a considerable amount of coincidence. The contours 
corresponding to these samples were calculated from samples diluted 10-fold with PBS; all 
other contours were calculated from undiluted samples to avoid excessive noise. 
Computational analysis of the data was performed by Stanislav Sokolenko as described in 
Nicastro et al. (2013).  
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4.5 EDTA Resistance in Decorated and Non-Decorated Phage 
To assess the structural integrity of λDam15 phage variably decorated by different 
gpD::eGFP and/or different isotypes of gpD, we next tested each of the phage samples grown 
at 37°C for resistance to EDTA (Table 5).  EDTA or Ethylenediaminetetraacetic acid, is a 
chelating agent that possesses the ability to sequester divalent metal cations such as Mg2+, 
which in turn acts to destabilize the λ phage capsid. We noted a significant variation in 
survival rates, whereby the lysate grown on SupE and the lysate prepared on Sup—[pD], both 
complementing the Dam15 mutation by a gpDwt allele, had the greatest EDTA resistance, 
with near optimal resistant progeny. Surprisingly, phage grown on SupF (gpDQ68Y), 
generating the gpDQ68Y allele, conferred only a 44% survival rate while those grown on 
SupD, generating the gpDQ68S allele, showed the poorest survival rate of 35%. The noted 
difference in survival rate can be attributed to the relatively stable packaging of gpDwt over 
either of the gpDQ68Y and gpDQ68S alleles.  Next, those variably decorated lysates 
prepared on Sup+ [pD::eGFP] showed relatively consistent survival rates among the samples 
ranging from 54-59%, albeit a drop in resistance from that seen with the packaging of gpDwt 
(SupE), and an increase in resistance from those packaging the gpDQ68Y allele (SupF) and 
gpDQ68S (SupD). Lysates developed on Sup— [pD::eGFP] showed a relatively low survival 
rate of 36%. The variable display of both the fusion protein with gpD::eGFP and the gpD 
alleles were observably more stable than either of the gpDQ68Y, gpDQ68S or the 
gpD::eGFP fusion allele alone, while those incorporating gpDwt were found to be the most 
resistant to EDTA. 
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Table 5: Variable susceptibility to EDTA exposure of λDam15 phage 
Strain [+ Plasmid] 1 Relative efficiency of plating (EOP) 2,3  
Sup— [pD] 0.93 ± 0.07 
Sup— [pD::eGFP] 0.36 ± 0.02 
SupD  [pD]- 0.35 ± 0.06 
SupD  [pD::eGFP] 0.59 ± 0.02 
SupE  [pD]- 0.91 ± 0.04 
SupE  [pD::eGFP] 0.54 ± 0.02 
SupF  [pD]- 0.44 ± 0.02 
SupF  [pD::eGFP] 0.57 ± 0.07 
1 Lysate produced on strain at 37oC. All strains are derivatives of W3101. 
2 Calculated from a minimum of three determinations, grown on BB4 (SupE, SupF).  
3 All EOP determinations were determined from a minimum of three assays and using the 
original universal determined concentration of 4 X 108 grown on BB4 (SupE, SupF) as the 
positive (100%) plating control.  
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4.6 Relationship between Fluorescence and Size of 
Decorated Phage Preparations 
A plot was developed to assess the relationship between the fluorescence and size ratios of 
decorated and non-decorated phage (Figure 19).  All phage samples were compared to the 
size of the undecorated control phage grown on SupE (gpDwt) in the absence of pD::eGFP. 
Undecorated negative controls were used as the base size for each sample batch. These 
samples were grown on Sup+ strains permitting the incorporation of respective wild-type 
length gpD alleles. Each series was plotted as a separate plot to best emphasize the 
relationship from each individual negative control. We noted a relationship between the 
decoration and size of phage whereby an increase to the number of decorated phage head 
particles saw a comparative increase to the phage head size in comparison to phage which 
only harbored the wild-type length alleles. This would be indicative of an increase to phage 
head complexity as previously mentioned (sections 4.2 and 4.3) as well as an overall change 
to the phage capsid diameter upon addition of the decorated fusions.  
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Figure 19: Separation of decorated phage preparations based on fluorescence emitted 
and size as determined by dynamic light scattering. Fluorescence and size ratios based on 
comparison to λDam15 grown on W3101 SupE (gpDwt) in the absence of a pD::eGFP 
plasmid. The measured sizes are reported using a percent intensity distribution. Each data 
point was automatically repeated in triplicate, and the average is reported. Sizing results are 
expressed based on “X” increase compared to λDam15 grown on the BB4 providing gpDwt 
and gpDQ68Y incorporation into the resultant phage capsid. Measured fluorescence data was 
analyzed by Stanislav Stokolenko using the SoftMaxPro V5 software based on 6 readings 
and the samples were run in duplicate with the average being reported. Phage samples were 
run alongside an eGFP standard to determine the protein concentrations of each sample.  The 
determined eGFP molecules per phage was interpolated through Excel against a derived 
equation of the trend-line from known eGFP purified protein fluorescence calibration curve 
and the weight of the eGFP molecule. Figure taken from Nicastro et al. (2013) 
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Chapter 5 : Discussion 
 
5 Discussion  
Maruyama et al. (1994) and Mikawa et al. (1996) first modulated total fusion protein 
incorporated on the capsid through the use of amber stop codons, located upstream of the V 
D genetic fusion. As such, the level of decoration was dependent on the strength of 
suppression supplied by the host bacterial Sup+ mutant through which the phage was 
passaged.  These initial studies provided a great foundation and premise for this work while 
also providing preliminary insight into some of the challenges that would be faced and 
complications to be overcome. Here, we sought to design and characterize a phage display 
platform to more finely control decoration of gpD fusions on the surface of λ phage, using 
eGFP as the fusion partner. This combines two competing genetic principles: 1) Generation 
of different alleles of gpD with different structural functionality suppressing the λDam15 
mutation; and 2) plasmid-borne D::X fusion expression regulated by temperature to 
complement the Dam15 mutation. We have shown here that through the combination of these 
two dimensions a wide breadth of permutations in phage decoration through gpD::X fusions 
can be achieved.  
The gpD::eGFP C-terminal fusion was able to complement and restore viability to the 
λDam15 phage, but despite the presence of the linker, the fusion was found to reduce 
functionality of the major capsid protein marginally in the Sup— host, compared to its 
unfused counterpart, which is likely due to the size of the fusion generated. Previously, Yang 
et al. (2000) noted that the presence of a large protein fusion disrupts phage assembly due to 
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the overloading of recombinant protein that decreases phage viability.  Vaccaro et al. (2006) 
later reported that fusion of a scFv sequence to the C-terminal of gpD employing a double 
gene D system and a flexible linker between the fusion peptide and gpD similarly resulted in 
smaller plaque size and reduced phage viability.   
The exact positioning of the λF7 (λDam15imm21ts) mutation was previously determined in 
our lab (Nicastro et al. 2013, Sheldon 2013) after sequencing of the 333 bp Dam15 allele to 
find that the amber mutation was localized to the 204th bp of D. This transition imparts the 
conversion of the 68th CAG codon (glutamine), to an amber translational stop signal (UAG) 
codon.  In a Sup— host the amber mutation imparts a premature translational stop resulting in 
a truncated 68 a.a. non-functional gpD fragment that is incapable of stabilizing and 
packaging full length λ DNA. Growing λ Dam15 phage on an amber suppressor host may 
result in a phenotypic a.a. substitution of glutamine residue at position 68. Only a SupE strain 
will code glutamine at the 68th codon restoring the pristine sequence of gpD, while SupD will 
confer a serine substitution, producing a gpDQ68S; and SupF will confer a tyrosine 
substitution, yielding gpDQ68Y.  
In this study, the assembly of viable phage depended on the tolerance of the  phage capsid 
for the gpD allele conferred by each of the suppressor strains, in addition to that of the 
gpD::eGFP fusions. While restoration of the pristine sequence (in SupE) was expected to 
restore full function to gpD, it was somewhat surprising that the substitution of the 
glutamine, a carboxamide, 146.2 Da, polar neutral a.a. with tyrosine, a bulky (181.2 Da), 
aromatic and hydrophobic a.a. restored nearly full viability to the λDam15 phage. Lastly, the 
substitution of glutamine with the albeit smaller (105.1 Da) serine (gpDQ68S) that is 
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biochemically similar as a polar neutral a.a., provided very little improvement compared to 
that on the Sup— (gpD—) in restoring viability to λ Dam15, and generated comparatively very 
small phage and pinpoint plaques in the absence of gpD or gpD::eGFP complementation.  
Possible reasons for the dramatic effect of the serine substitution at residue 68 of gpD 
(Nicastro et al. 2013, Sheldon 2013) include interference in gpD trimerization and/or 
compromised interaction with gpE hexamers, although previous findings indicate that the N-
terminus is located closer to the 3-fold axis of the gpD trimer (Yang et al. 2000) and may be 
involved with interacting with gpE. The functionality of gpD derivatives was similarly 
reflected in phage sizing of undecorated phage. SupD phage preparations carrying the 
gpDQ68S allele were only a third the size of wild type (SupE) and SupF preparations. While 
SupE and SupF host progeny likely possessed close to a full complement (405-420) of gpD 
per capsid, SupD phage progeny instability is likely due to being minimally decorated.  To 
assess stability, we examined EDTA resistance of various preparations in presence and 
absence of D::eGFP expression and found that phages carrying the gpDQ68S protein were 
the most unstable. The instability of phage yielded from these preparations explains the large 
variation in eGFP per phage and sizing found for this group, whereby these phage are likely 
prone to capsid disassembly. This instability was similarly found for phage assembled in the 
presence of the fusion alone; again indicating that stability necessitates the capsid 
incorporation of gpD in order to stabilize fusion decoration.  
Despite the potential 405 to 420 gpD incorporations into the phage capsid, our results suggest 
that the highest incorporation possible using our system was only 147 gpD::eGFP 
molecules/phage. Even in the absence of gpD (on Sup—) the incorporation of gpD::eGFP was 
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restricted to 115 molecules per phage, indicating that a full complement of gpD is not 
necessary to restore viability to λDam15 and that in the absence of a wild type or gpD 
derivative, fusion incorporation into the phage is limited. Mikawa et al. (1996) previously 
reported that a scenario where all gpD sites on the capsid were occupied by C-terminal gpD 
fusion proteins was not achievable, as resultant phage were still sensitive to EDTA, 
indicative of empty gpD sites. Similarly, in this study, phage samples prepared at 35˚C were 
found to complement for viability reasonably well despite the relatively low levels of 
gpD::eGFP incorporation, which was only source of gpD in this preparation. These samples 
were found to only harbour 44 gpD::eGFP molecules/phage (~10% of available gpD capsid 
sites), which was corroborated by a smaller reported average phage diameter.  
 Mikawa et al. (1996) showed that plasmid copy number does affect the level of expression 
and therefore ability to complement for a D mutation (Mikawa et al. 1996; Sternberg and 
Hoess 1995). In this work, plasmid copy number was not used as an approach to control 
decoration and a multicopy plasmid was employed for all constructs, but this may be of 
interest in future studies where multiple fusions could be incorporated simultaneously into a 
phage capsid. The manipulation of plasmid copy number could provide a third dimension of 
control. Zucconi et al. (2001) and Minenkova et al. (2003) also found that the number of 
fusion proteins displayed on the λ capsid surface varied depending on the length and a.a. 
composition of the foreign sequence expressed at the C-terminal of gpD. Santini et al. (1998) 
also observed a similar result where fusion of large protein domains to gpD significantly 
reduced the titer of phage when grown on Sup— compared to Sup+ strains. This finding 
indicated that incorporating wild-type D protein is preferential for proper assembly, and that 
 75   
 
the use of suppressor strains is advantageous (Santini et al. 1998). Similarly, Yang et al. 
(2000) also reported that the interference in phage assembly they noted by overloading the 
phage with fusion protein was not observed in previous studies where recombinant protein 
was incorporated with wild-type gpD, again suggesting the role of wild type gpD in 
improving incorporation of the fusion (Yang et al. 2000).  
While suppression correlated well to restoration of phage viability, the opposite was true 
when we examined fluorescence of the various phage preparations in the presence of 
D::eGFP expression. Phage prepared on the best suppressors showed low fluorescence even 
under conditions of high gpD::eGFP production, while the SupD suppressor offered the 
highest levels of eGFP phage decoration, even under conditions where D::eGFP expression 
was only leaky (30oC). Previous studies similarly reported that low yields and decreased 
phage viability are associated with greater expression of capsid-fusion protein, although at 
the time it was not clear whether this observation was due to impaired capsid assembly 
(Mikawa et al. 1996;  Maruyama et al. 1994).  
We attribute this finding to the accumulation of gpD derivatives, or intragenically 
complementary heterotrimers with higher functionality into the capsid, thereby reducing the 
incorporation of the less preferred allele or homo/heterotrimer combinations. In the case of 
SupE and SupF host preparations, the full length gpD alleles were preferred over the 
gpD::eGFP fusion even at high levels of expression, thereby reducing fluorescence to the 
resultant phage. In contrast, in SupD preparations, the preferred allele may be gpD::eGFP 
that “outcompetes” the gpDQ68S allele for placement into the capsid, resulting in stronger 
decoration. These inferences are supported by phage sizing data, which demonstrate a 
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positive correlation between fluorescence and size of the resultant phage particles (Figure 1). 
This data supports the assumption that the amount of eGFP fusions on the phage surface can 
be quantified through florescent measurements and that with an increase in gpD::eGFP 
fusions, a proportional increase in the phage diameter would be expected. This data was 
similarly demonstrated by cytometry analysis of fluorescence and side scatter. Here, the 2D 
fluorescence/side-scatter density distribution (Figure 18) corroborated fusion decoration 
trends and as previously suggested (Sokolenko et al. 2012), indicated increasing side scatter 
alongside heightened fluorescence (eGFP decoration), relating phage surface complexity to 
degree of capsid fusion incorporation. 
While the eGFP phage decoration profile fits well for increasing D::eGFP derepression from 
30o through 37oC, at the highest level of fusion expression from λ pL (39–40oC), where 
CI857 repressor is completely labile, gpD::eGFP phage decoration decreases compared to 
that at 37oC on all host cell line preparations. We attribute this finding to the mode of lysate 
preparation that exposes host cells to heat-shock temperatures for several hours, altering cell 
physiology and increasing concentration of heat shock response proteins (Hsp) factor (Gill et 
al. 2000, Smith 2007, Valdez-Cruz et al. 2010). This response includes the up-regulation of 
genes coding for heat shock proteins and SOS response, with the particular attention to 
proteases such as clpP, degP, ftsH, ompT and lon, regulated by the σ32 sigma factor. 
Temperature inducing up-shifts impart high physiological stress to the host cell that results in 
a three-fold increase in global protein synthesis, a quarter of which is devoted to Hsp 
synthesis (G. Wegrzyn and Wegrzyn 2002;  Hoffmann and Ursula Rinas 2001; Zhao et al. 
2005; Yamamori and Yura 1980;  Hoffmann and Rinas 2000; Valdez-Cruz et al. 2010), 
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thereby reducing growth rates and recombinant protein yield ( Wegrzyn and. Wegrzyn 2002; 
Valdez-Cruz et al. 2010; Zhao et al. 2005). Also, recombinant proteins produced using 
thermoinduction systems, particularly from multicopy plasmids as in this work, can result in 
high protein concentrations and the formation of inclusion bodies, removing these proteins 
from the functional fusion population (Babu et al. 2000;  Rinas and  Hoffmann 2004; Caspeta 
et al. 2009; Vallejo et al. 2002; Valdez-Cruz et al. 2010).  
The potential downstream applications of this research are primarily the construction of 
multivalent phage vaccines and/or the development of vehicles for phage-mediated targeted 
gene therapy. These applications exhibit the two endpoints of the spectrum of phage surface 
display control. While vaccination would expectedly be most effective if display saturation 
was reached, targeted transgene delivery applications would require a high-level of 
specificity in targeting unique receptors of appropriate cells, where fewer and controlled 
fusions are usually preferable. It is important to note that while our system demonstrates a 
fair degree of variability in eGFP decoration, these results are only useful in relative 
comparison of phage decoration conditions. Absolute display will be dependent upon the size 
and biochemical attributes of the fused candidate and the tolerance of gpD and the foreign 
polypeptide to fusion.  
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Chapter 6: Conclusion 
 
The intention of this work is to develop a phage display platform that permits the stable and 
highly-controllable phage display via two-dimensional genetic control over the co-expression 
of gpD alleles and a gpD::eGFP fusion protein on temperate bacteriophage λ. This system 
utilizes the bacteriophage λ capsid protein gpD for the fusion of eGFP polypeptides for the 
efficient display on the surface of the phage. Amber suppression control was established 
through the use of gpD alleles generated during λ Dam15 infection of Sup+ isogenic 
derivatives. These particles carry gpD alleles of varying functionality depending on the 
amber suppressor strain of E. coli, SupD (gpDQ68S), SupE (Dwt) or SupF (gpDQ68Y) host 
on which they were grown. In combination, temperature control was employed through the 
use of the D-fusion protein, gpD::eGFP, encoded in trans from a multicopy temperature-
inducible expression plasmid regulated by the  CI857 repressor.  This combinational control 
system generated dramatic variation in the expression of displayed peptides through the 
many permutations afforded by the dual mechanisms of control. Maximal incorporation of 
gpD::eGFP into the λDam15 phage capsid was imparted in combination with the gpDQ68S 
allele, despite the fact that SupD proved to be the worst suppressor of the Dam15 mutation. 
Temperature-regulated D::eGFP fusion expression from the pD::eGFP plasmid in 
combination with functional breadth of gpD alleles afforded by variable suppression of 
Dam15 conferred resultant phage that differed in size, fluorescence and absolute protein 
decoration (Nicastro et al. 2013, Sokolenko et al. 2012).  
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Phage display offers many important applications to date and a fine-tuned system as 
mentioned in this work could significantly improve future applications by tailoring 
decoration to the needs of the application at hand. The industrial use of phage display has 
been increasing in interest. Although the applications have been significant, the use of phage 
display in industry has seen primarily horizontal growth, where the system has remained 
virtually identical, but the number of applications has been increasing. With respect to 
clinical applications, the two-gene system has empowered phage display in therapeutic 
design; however, control of the fusion copy number is highly necessary but has to date 
proven a formidable obstacle. For example, phage vaccines need maximal expression of the 
target antigen to induce a strong response (Hayes et al. 2010), which can be an issue with the 
two gene-systems, since they will normally result in a greater number of wild-type protein 
(Enshell-Seijffers et al. 2001).  Mammalian gene delivery systems also require control of 
copy number such that the phage vectors display a combination of peptides (Lankes et al. 
2007).  The incorporation of control over fusion decoration is critical to the efficacy of 
phage-based biotherapeutics and the work described here makes strong inroads into 
addressing this issue.  
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Future research objectives: 
1) Continued and completed analysis testing the expression at the carboxy terminal of 
the D::gfp fusion on the amber suppressor strains with the plasmid for the 
incorporation of D::eGFP under the control of a temperature cI857 sensitive 
repressor.   
2) Exploitation of the system to clinically relevant peptides and fusions including those 
for vaccine delivery and the development of a universal antimicrobial.  
3) Construction of a system that is transferrable to N15 and create N, C and N+C 
terminal fusions with gp7 
4) TEM (Transmission Electron microscope) imaging of the displayed peptides  
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